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Abbreviations  
Ar   aryl 
Å   Ångström 
Bn   benzyl 
Bu   butyl 
br   broad 
Cy   cyclohexyl 
°C   degree celsius 
cod   cis-1,5-cyclooctadiene 
d   doublet 
!   chemical shift (ppm) 
Et   ethyl 
equiv.   equivalents 
FDA   U.S. Food and Drug Administration 
g   gram 
GC   gas chromatography 
h   hours 
HPLC   high performance liquid chromatography 
Hz   Hertz 
J   coupling constant (Hz) 
K   Kelvin 
m   multiplet 
Me   methyl 
min   minute 
mL   milliliter 
mmol   millimol 
MS   mass spectrometry 
NMR   nuclear magnetic resonance 
Ph   phenyl 
Pr   propyl 
q   quartet 
(R)   rectus (right) 
rt   room temperature 
s      singlet 
(S)   sinister (left) 
t   triplet 
!L   microliter 
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1. Summary / Zusammenfassung 
1.1 Summary 
In the context of this thesis two classes of novel imidazo[1,5-b]pyridazine-substituted 
amines 2 were developed. Imidazo[1,5-b]pyridazine-substituted amines can be 
synthesized in high purity and good yields via the nucleophilic ring transformation of 
oxadiazolium halides 1 and N-nucleophiles, followed by deacetylation and 
cyclocondensation with 1,3-diketones. The deprotonated amines can act as 
monoanionic amido-ligands.  
Previous results regarding diamine-bridged imidazo[1,5-b]pyridazines have shown, 
that the deprotonated compounds are suitable for the stabilization of early as well as 
late transition metal complexes. Since only dinuclear group 9 metal complexes could 
be obtained, one objective of this work was to enable the synthesis of mononuclear 
amido-complexes by means of a novel ligand structure. Thus, a series of 
imidazo[1,5-b]pyridazine-substituted (pyridylmethyl)amines was synthesized via a 
one-pot approach. Salt metathesis or alcohol elimination route were chosen for the 
synthesis of the iridium amido-complexes. The (2-pyridylmethyl)amine-derived 
complexes exhibited an unusual reactivity in solution. An intermolecular C-C coupling 
reaction of the mononuclear complexes was observed, yielding a dimeric species. 
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Based on mechanistic and kinetic investigations, it was postulated that the coupling 
reaction is due to tautomerization yielding an enamido hydrido complex, which 
subsequently undergoes an intermolecular attack. This gives rise to the dimeric 
species with iridium mediated hydrogen evolution.  
Because of the modular ligand design, optically active imidazo[1,5-b]pyridazine-
substituted amines can easily be obtained via the utilization of chiral N-nucleophiles 
such as amino alcohols. Motivated by previous results regarding chiral imidazo[1,5-
b]pyridazine-stabilized iridium amido-complexes, which exhibit high selectivities and 
good activities in the asymmetric hydrogenation of ketones, the development of 
amido-complex catalysts for the enantioselective hydrogenation of imines represents 
a major focus of this work. A library of novel amines 4 was synthesized by 
deprotonation of the hydroxyl function of 3 with nBuLi followed by the addition of 
chlorophosphines or chlorophosphite.  
Alcohol elimination reaction of 4 with 0.5 equiv. of [MOCH3(cod)]2 (M= Ir, Rh) gave 
rise to transition metal amido-complexes, which were applied to the asymmetric 
hydrogenation of N-aryl imines.  
Upon activation with KOtBu moderate initial selectivities and good activities were 
obtained for rhodium amido-complexes. Following the optimization of the reaction 
conditions (temperature, pressure, base) a ligand screening was performed. The 
highest activities and selectivities in the asymmetric hydrogenation of various imines 
were obtained by combining electron donating P-substituents (iPr) and amino 
alcohols (iBu). Additionally, the catalyst loading was reduced from 1 mol%, which 
represents the common usage, to only 0.1-0.2 mol%.   
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Thus, a novel ligand motif, based on chiral imidazo[1,5-b]pyridazines, was 
established for the efficient rhodium-catalyzed asymmetric hydrogenation of N-aryl 
imines.  
In the third section of this thesis a novel potassium-mediated synthesis of 6-
aminofulvenes from N-aryl imines is introduced. During the hydrogenation 
experiments regarding the optimization of the added base, the formation of a by-
product was observed, if potassium hydride was utilized as a base. The by-product 
could be identified as novel 6-aminofulvene, namely [(2,4-diphenyl-cyclopenta-2,4-
dienylidene)-phenyl-methyl]-phenyl-amine.   
Upon this exciting discovery, the reaction conditions leading to fulvene formation 
were explored by means of reaction stoichiometry and added base. The resulting 
novel synthesis route was applied to various N-aryl imines.  
Mechanistic as well as kinetic investigations indicated, that the reaction is based on 
the formation of the metalated enamine, which nucleophilicly attacks the imine-
carbon. The herein reported new synthesis method provides an easy access to novel 
6-aminofulvenes. 
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1.2 Zusammenfassung 
Im Rahmen der vorliegenden Arbeit wurden zwei Klassen neuartiger Imidazo[1,5-
b]pyridazin-substituierter Amine 2 dargestellt. Imidazo[1,5-b]pyridazin-substituierte 
Amine können durch nukleophile Ringtransformation von Oxadiazoliumhalogeniden 1 
mit N-Nukleophilen und anschließender mit Entacetylierung gekoppelter 
Cyclokondensation mit 1,3-Diketonen in hoher Reinheit und guter Ausbeute erhalten 
werden. Die deprotonierten Amine können als monoanionische Amido-Liganden 
aufgefasst werden.  
Frühere Arbeiten zu diamin-verbrückten Imidazo[1,5-b]pyridazinen haben gezeigt, 
dass diese in deprotonierter Form hervorragend zur Stabilisierung von frühen und 
späten Übergangsmetallkomplexen geeignet sind. Da jedoch für Metalle der Gruppe 
9 lediglich zweikernige Komplexe erhalten werden konnten, war ein Ziel dieser Arbeit 
den Übergang zu mononuklearen Komplexen durch eine neuartige Ligandenstruktur 
zu ermöglichen. Hierzu wurden in einer Eintopfsynthese verschiedene Imidazo[1,5-
b]pyridazin-substituierte (Pyridylmethyl)amine in moderater bis guter Ausbeute und 
hoher Reinheit dargestellt. Anschließend wurden diese durch Salzmetathese oder 
Alkoholeliminierung mit einer Iridium-Vorstufe zu den entsprechenden Iridium-Amido-
Komplexen umgesetzt. Es wurde dabei für die (2-Pyridylmethyl)-substituierten 
Komplexe eine außergewöhnliche Reaktivität beobachtet. Eine intermolekulare C-C-
Kupplungsreaktion zwischen den mononuklearen Iridium-Amido-Komplexen führte 
zur Bildung einer zweikernigen Spezies.  
Basierend auf mechanistischen und kinetischen Untersuchungen wurde postuliert, 
dass diese Kupplungsreaktion auf der Tautomerisierung zum Enamido-Hydrido-
Komplex beruht. Anschließend bildet sich durch intermolekularen Angriff die 
zweikernige Spezies, wobei Iridium-vermittelt Wasserstoff freigesetzt wird. 
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Auf Grund des modularen Liganden-Designs können durch die Verwendung von 
chiralen N-Nukleophilen, wie Aminoalkoholen, optisch aktive Imidazo[1,5-b]pyridazin-
substituierte Amine erhalten werden. Motiviert durch vorhergehende Arbeiten zu 
chiralen Imidazo[1,5-b]pyridazin-stabilisierten Iridium-Amido-Komplexen, welche 
hervorragende Aktivitäten und Selektivitäten in der asymmetrischen Hydrierung von 
Ketonen aufweisen, war die Entwicklung von Amido-Komplexkatalysatoren für die 
asymmetrische Hydrierung von Iminen ein Schwerpunkt dieser Arbeit. 
Durch Lithiierung der Hydroxyfunktion von Imidazo[1,5-b]pyridazin-substituierten 
Aminoalkoholen 3 und anschließender Umsetzung mit Chlorophosphanen oder 
Chlorophosphit konnten verschiedene neuartige Amine 4 in hohen Ausbeuten und 
hoher Reinheit erhalten werden.  
Diese wurden anschließend durch Alkoholeliminierung zu Amido-
Übergangsmetallkomplexen (Ir, Rh) umgesetzt und in der asymmetrischen 
Hydrierung von N-Aryliminen getestet.  
Durch die Zugabe von KOtBu konnten in den ersten Hydrierexperimenten für 
Rhodium-Amido-Komplexe moderate Selektivitäten und gute Aktivitäten erhalten 
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werden. Nach Optimierung der Reaktionsbedingungen (Temperatur, Druck, Base) 
wurde ein Ligandenscreening durchgeführt. Die höchsten Selektivitäten und 
Aktivitäten in der enantioselektiven Hydrierung von verschiedenen N-Aryliminen 
wurden mit der Kombination aus elektronenschiebenden P-Substituenten (iPr) und 
Aminoalkoholen (iBu) erzielt. Die Katalysatorbeladung konnte dabei von in der 
Literatur üblichen 1 mol% auf 0.1-0.2 mol% gesenkt werden. 
Basierend auf chiralen Imidazo[1,5-b]pyridazinen wurde somit ein neuartiges 
Ligandenmotiv für die hoch effiziente Rhodium-katalysierte asymmetrische 
Hydrierung von Iminen etabliert.  
Im dritten Abschnitt der vorliegenden Arbeit wird eine neue Kalium-vermittelte 
Syntheseroute für 6-Aminofulvene ausgehend von N-Aryliminen beschrieben. Bei 
den Untersuchungen zur Basen-Optimierung in der Hydrierung wurde bei KH-
Zugabe die Bildung eines Nebenproduktes beobachtet. Dieses Nebenprodukt konnte 
als neuartiges 6-Aminofulven, [(2,4-Diphenyl-cyclopenta-2,4-dienyliden)-phenyl-
methyl]-phenyl-amin, identifiziert werden.  
Anschließend wurden die Reaktionsbedingungen (Stöchiometrie, Base), welche zur 
Fulvenbildung führen, ermittelt und die neuartige Syntheseroute auf verschiedene N-
Arylimine angewendet.  
Auf Grund mechanistischer und kinetischer Untersuchungen wurde ein 
Reaktionsmechanismus postuliert. Dieser basiert auf der Bildung von kaliierten 
Enaminen, welche nukleophil am Imin-Kohlenstoff angreifen. Die hier erstmals 
vorgestellte Syntheseroute bietet einen einfachen Zugang zu neuen 6-
Aminofulvenen. 
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2. Introduction 
Following the pioneering works of Bradley, Lappert and others[1,2], who established 
the basic structural motifs and synthetic procedures for amido-ligands (NR2-) in the 
1960’s and 1970’s, amido-metal chemistry has played a minor role until the mid 
1990’s.  
The search for ligand systems, which allow for reactivity modification of the resulting 
transition metal complexes e.g. in homogeneous catalysis, is one of the main 
challenges in today’s chemistry. The most important advantage of amido-ligands is 
the possibility to substitute the amido-N-atom at two positions.[3] Thereby, new 
functionalities can be introduced, which mask reaction sites due to a hemilabile 
coordination behavior. This has led to the renaissance of amido-metal chemistry 
during the last decade.[4] 
Recently, we introduced a novel bisamido-ligand system, which is based on diamine-
bridged imidazo[1,5-b]pyridazines.[5] The deprotonated diamines are suitable for the 
stabilization of early as well as late transition metal complexes via a five-membered 
chelate. Since the reaction with group 9 metals yielded only dinuclear complexes, we 
were interested in developing an amido-pincer type of ligand, which allows for the 
synthesis of mononuclear amido-complexes. Furthermore, the ligand should possess 
multiple (hemilabile) coordination sites to enable coordination flexibility and reactivity. 
In this work a series of novel imidazo[1,5-b]pyridazine-substituted (pyridylmethyl)-
amines was developed and applied for the stabilization of iridium complexes, which 
exhibit an interesting reactivity in solution.  
Due to the modular design of imidazo[1,5-b]pyridazine-substituted amido-ligands, a 
wide range of amines can be utilized for their synthesis. This additionally permits the 
introduction of chirality e.g. via the chiral pool approach. 
Since nature is based on homochirality[6], many biological processes, for instance 
enzyme catalysis, signal transduction or molecular recognition, are inherently 
dissymmetric. Enzymes and receptor sites are capable of differential binding, thereby 
distinguishing the enantiomers. The biological responses, which are generated upon 
binding, differ for each enantiomer (Table 1).[7] The undesired enantiomer can either 
be inactive (‘metabolic waste’) or have an unwanted, even toxic effect.[8,9] Thus, 
2. Introduction 
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certain chiral active pharmaceutical ingredients should be employed as enantiopure 
compounds. 
Table 1: Different biological activities of drug enantiomers.[8,9] 
Compound  Absolute Configuration Biological Activity 
R toxic 
1-chloropropane-2,3-diol 
 
S anti-fertility 
R causes granulocytopenia 
dopa 
 
 S anti-parkinson 
R,R causes blindness 
ethambutol 
 
 S,S tuberculostatic 
R contraceptive 
propranolol 
 
 
S anti-arrhythmic, decrease of blood pressure 
Due to the fact that about 80% of the pharmaceuticals in the product pipeline are 
chiral and furthermore that the FDA is improving the regulations for the launch of 
chiral pharmaceutical ingredients, there is an increasing demand for optically active 
intermediates such as amines, alcohols or acids.[10,11] This ‘chiral switch’ in the 
pharmaceutical industry has boosted the field of asymmetric catalytic technologies, 
since these provide excellent access to those substances. 
In general asymmetric catalytic technologies are divided into chemocatalysis and 
biocatalysis. Biocatalysis is based on soluble or immobilized enzymes that are either 
applied in an isolated form or as whole cell catalysts.[12] Mainly chiral transition metal 
complexes are applied for asymmetric chemocatalytic reactions, since virtually no 
restrictions exist regarding their molecular design.[13]  
Thus, great efforts have been made to develop novel chiral ligand-systems for 
asymmetric catalysis. This ‘ligand-evolution’ is demonstrated through the history of 
asymmetric hydrogenation technologies. Based on Wilkinson’s achiral [Rh(PPh3)3Cl] 
hydrogenation catalyst[14], Horner as well as Knowles utilized butyl-methyl-
phenylphosphine as chiral P-ligand.[15] The enantioselectivity in the hydrogenation of 
olefines was still rather low, but soon more effective P-chirogenic phosphine ligands 
such as camp[16] (camp = cyclohexyl-o-anisylmethylphosphine) and dipamp[17] 
(dipamp = ethylenebis[(2-methoxyphenyl)phenylphosphine]) were established. Since 
OHCl
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OH
O
HO
HO
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the introduction of diop[18] (diop = 4,5-bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-
dioxolane) by Kagan et al. the research focused on the development of C2-symmetric 
ligands, the most prominent examples being binap[19] (binap = 2,2!-
bis(diphenylphosphino)-1,1!-binaphthyl) and duphos[20] (duphos = 1,2-bis-[2,5-
dialkylphospholano]benzene). More recently additional structural motifs such as the 
josiphos family[21] and phosphine-oxazolines (phox)[22] were introduced (Figure 1). 
Figure 1: Optically active ligands applied in asymmetric hydrogenation reactions. 
In general three approaches can be adopted for the synthesis of chiral ligands: the 
resolution of a racemic mixture, the utilization of chiral building blocks (chiral pool 
approach) and the conversion of a prochiral substrate via asymmetric (bio)catalysis 
(amplification of chirality).[23] 
Chiral amino acids (chiral pool) and amino alcohols (reduction of amino acids), which 
are easily accessible, represent ideal building blocks for the synthesis of chiral 
imidazopyridazine-substituted amines.  
Imidazo[1,5-b]pyridazine-substituted amino alcohols can be synthesized via a one-
pot approach in good yields and high purity. Upon deprotonation they can be utilized 
for the stabilization of iridium amido-complexes, which show excellent activities and 
selectivities in the asymmetric hydrogenation of ketones.[24]   
Based on these promising results, one of the objectives of this work is to find an 
amido-catalyst system, which is suitable for the asymmetric hydrogenation of imines. 
Since the hydroxyl function can easily be targeted for functionalization reactions, a 
novel ligand system was developed by introduction of P-substituents. 
Within this work a library of novel amino-P-ligands was synthesized, fully 
characterized and reacted with metal precursors to yield transition metal amido-
complexes. These amido-complexes were tested in the asymmetric hydrogenation of 
N-aryl imines. Upon optimization of the reaction conditions and a catalyst screening, 
the most promising catalyst system was utilized for the broadening of the substrate 
scope.
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 3. Overview of Thesis Results 
This thesis comprises 3 publications, which are presented in chapter 4-6. 
3.1 An Intermolecular C–C Coupling Reaction of Iridium Complexes 
Recently, our group reported the synthesis of novel imidazo[1,5-b]pyridazine-
substituted bisamido-ligands. Salt metathesis reaction with group 9 metals afforded 
only dinuclear complexes. We were interested in mononuclear group 9 amido-
complexes, which possess coordination flexibility in order to generate reactivity. 
Thus, a novel amido-pincer type of ligand, namely imidazo[1,5-b]pyridazine-
substituted (pyridylmethyl)amines 1, was developed.  
Salt metathesis or alcohol elimination reaction gave rise to mononuclear iridium 
complexes in good yields. The (2-pyridylmethyl)amine-derived complexes 2a-b were 
rather unstable in solution. An intermolecular C-C coupling reaction to dinuclear 
species, in which another coordination mode is realized, was observed. In order to 
elucidate the driving force of this coupling reaction, kinetic as well as mechanistic 
studies were performed. The coupling reaction is not likely to take place via a radical 
based mechanism, because the addition of a radical scavenger does not inhibit the 
reaction or decrease the rate of dimer formation. Since (3-pyridylmethyl)amine-
derived complex 2c does not perform the C-C coupling reaction, we propose that the 
mechanism is based on formation of an iridium enamido hydrido complex, 
intermolecular attack and iridium mediated hydrogen evolution. 
N
N
NR N
X
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N
N
N
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N
N
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N
N
N
R
N
N
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!t, !T
N
N
NR N
H
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Y
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+ 0.5 [IrOCH3(cod)]2 or
+ nBuLi, 0.5 [IrCl(cod)]2
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 0.5
1a: R=Ph, Y=N, X=C
1b: R=tBu, Y=N, X=C
1c: R=Ph, Y=C, X=N
2a-c
3a-b
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3.2 Novel Amido-Complexes for the Efficient Asymmetric Hydrogenation of 
Imines  
Based on previous results regarding the synthesis of chiral imidazo[1,5-b]pyridazine-
substituted amino alcohols, which are suitable for the stabilization of transition metal 
amido-complexes, a novel optically active amido-ligand system was developed.  
Thereby the hydroxyl function of imidazo[1,5-b]pyridazine-substituted amino alcohols 
was selectively deprotonated with nBuLi and subsequently one equiv. of a 
chlorophosphine or chlorophosphite was added, giving rise to novel amines in high 
yield and purity.  
The chiral amines were utilized for the stabilization of group 9 metal complexes (Ir, 
Rh) via alcohol elimination route. The resulting amido-complexes were applied to the 
asymmetric hydrogenation of various N-aryl imines.  
Since promising initial selectivities and activities were obtained for rhodium amido-
complexes, these were chosen for the optimization of the reaction. Thus, first the 
ideal reaction conditions by means of reaction temperature, pressure and the added 
base were determined. Next a ligand screening was conducted to find the best 
combination of amino alcohol and P-substituent. Therein, the combination of leucinol 
and -PiPr2 provided the best selectivity and activity in the asymmetric hydrogenation 
of various N-aryl imines. 
N
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3.3 The Potassium Hydride Mediated Trimerization of Imines 
During the asymmetric hydrogenation of N-(1-phenylethylidene)-aniline the formation 
of a by-product was observed, if potassium hydride was utilized as a base. The by-
product could be identified as a novel aminofulvene, namely [(2,4-diphenyl-
cyclopenta-2,4-dienylidene)-phenyl-methyl]-phenyl-amine.  
In order to reproduce this novel potassium-mediated fulvene synthesis, the ideal 
reaction-stoichiometry and the utilization of different metal bases was explored. 
Therein complete conversion of the imine and formation of the fulvene as main 
product was achieved upon addition of 0.7 equivalents of KH. Based on these 
results, several N-aryl imines were applied to the synthesis of aminofulvenes. 
Kinetic and mechanistic experiments were performed to gain insight into the 
mechanism of the imine trimerization reaction. 
It was found that upon base addition the metalated enamine is formed. Experiments 
regarding the reaction stoichiometry indicated that the imine and its enamine 
tautomer are involved in the reaction. It was postulated that the reaction is based on 
the nucleophilic attack of the enamine at the imine-carbon, thus potassium-anilide is 
eliminated. A second nucleophilic attack gives rise to the trimerization product, which 
subsequently cyclizes yielding the aminofulvene. 
N
KN
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-2 H2N-C6H5
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3.4 Individual Contribution to Joint Publication 
The results presented in this thesis were obtained in collaboration with others and 
are published, submitted or are to be submitted as indicated below. In the following, 
the contributions of all the co-authors to the publications are specified. The asterisk 
denotes the corresponding authors. 
3.4.1 Chapter 4 
This work was published in New J. Chem. 2010, 34, 1954-1960 with the title ‘An 
Intermolecular C–C Coupling Reaction of Iridium Complexes’ 
K. Kutlescha, Torsten Irrgang and Rhett Kempe* 
I synthesized and characterized all complexes and ligands presented in this work, 
carried out the NMR-experiments and wrote the publication. Torsten Irrgang carried 
out previous experiments regarding the synthesis of imidazopyridazine-substituted 
amido-ligands and was involved in scientific discussions and corrections of the 
manuscript. Rhett Kempe supervised this work and was involved in scientific 
discussions and correction of the manuscript. 
3.4.2 Chapter 5 
This work has been accepted for publication in Adv. Synth. Catal. with the title ‘Novel 
Amido-Complexes for the Efficient Asymmetric Hydrogenation of Imines’ 
K. Kutlescha, Torsten Irrgang and Rhett Kempe* 
I synthesized and characterized all complexes, ligands and imines presented in this 
work, carried out the NMR- and hydrogenation experiments and wrote the 
publication. Torsten Irrgang carried out previous experiments regarding the synthesis 
of imidazopyridazine-substituted amido-ligands and was involved in scientific 
discussions and corrections of the manuscript. Rhett Kempe supervised this work 
and was involved in scientific discussions and correction of the manuscript. 
3.4.3 Chapter 6 
This work has been submitted to Chem. Commun. with the title ‘The Potassium 
Hydride Mediated Trimerization of Imines’ 
K. Kutlescha, G.T. Venkanna and Rhett Kempe* 
3.4 Individual Contribution to Joint Publication 
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I established the synthesis of novel fulvenes, carried out NMR-, GC-MS- and kinetic 
experiments in order to propose the mechanism and wrote the publication. G. T. 
Venkanna utilized this methodology for the synthesis of various fulvenes, thereby 
demonstrating the applicability of this novel synthesis route towards other imines. 
Rhett Kempe supervised this work and was involved in scientific discussions and 
correction of the manuscript. 
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4. An Intermolecular C–C Coupling Reaction of Iridium 
Complexes 
Kathrin Kutlescha,[a] Torsten Irrgang[a,b] and Rhett Kempe*[a] 
[a] Lehrstuhl für Anorganische Chemie II, Universitätsstraße 30, NW I, 95440 
Bayreuth, Germany. Fax: +49 (0) 921-55-2157, E-mail: kempe@uni-bayreuth.de     
[b] AIKAA-Chemicals GmbH, Kämmereigasse 11, 95444 Bayreuth, Germany 
Keywords: Amido-Ligands, C-C Coupling, C-H Activation, Imidazo[1,5-b]pyridazines, 
Iridium, N-Ligands 
Published in: New. J. Chem. 2010, 34, 1954-1960. 
Abstract: Novel imidazo[1,5-b]pyridazine-substituted (pyridylmethyl)amines were 
synthesized via the nucleophilic ring transformation of oxadiazolium halides and 
(pyridylmethyl)amines, followed by a cyclocondensation reaction with 1,3-diketones. 
After deprotonation, these monoanionic amido-pincer-ligands are suitable for the 
stabilization of mononuclear iridium complexes. For (2-pyridylmethyl)amine-derived 
complexes, we observed the formation of dimers via an intermolecular C-C coupling 
reaction, whilst the (3-pyridylmethyl)amine-derived complex did not react. We 
propose that enamine tautomerization plays an important role in the C-C coupling 
reaction. 
4.1 Introduction  
Recently, we described a novel ligand system for the stabilization of early and late 
transition metal complexes- imidazopyridazine-substituted bisamido-ligands (Scheme 
1).[1] Since salt metathesis reactions with group 9 metals (Ir, Rh) yielded only 
dinuclear amido-complexes with trans binding modes, we were interested in 
developing an amido-pincer type of ligand[2] that allows for the synthesis of 
mononuclear complexes (Scheme 1). 
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Scheme 1: Imidazo[1,5-b]pyridazine-substituted bisamido-ligands and amido-pincer-
ligands (R1–3 = aryl or alkyl substituents; Y, X = C or N). 
Our approach towards these novel amido-pincer-ligands is based on classical bench-
top chemistry, realizing a large variety of substitution patterns. Aryl amines are 
substantially synthesized via palladium-catalyzed aryl amination, which is efficient for 
the formation of C–N bonds but often employs rather expensive catalysts.[3] 
Herein, we report the synthesis of imidazo[1,5-b]pyridazine-substituted 
(pyridylmethyl)amines 5 and their application as monoanionic ligands for the 
stabilization of iridium complexes 6. For 6a and 6b, we observed an unusual 
intermolecular C–C coupling reaction, giving rise to dinuclear complexes 7. 
4.2 Results and Discussion 
2-Amino-5-methyl-1,3,4-oxadiazolium halides[4] 1a and 1b (Scheme 2) react with a 
large variety of N-nucleophiles, such as primary and secondary amines, to yield 2-
amino-substituted 1-acetylamino-imidazoles via a nucleophilic ring transformation.[5,6] 
Thus, the reaction with (pyridylmethyl)amines affords N-{4-alkyl/aryl-2-[(pyridin-2/3-
ylmethyl)-amino]-imidazo-1-yl}-acetamides 2a-c.  
Deacetylation by refluxing 2 in EtOH/HCl, followed by neutralization, gives rise to 4a-
c (Scheme 2). It is known that 1-amino-4-aryl-imidazoles[7] react with 1,3-diketones to 
yield imidazo[1,5-b]pyridazines.[6] Analogously, 4 can be converted into imidazo[1,5-
b]pyridazine-substituted (pyridylmethyl)amines 5a-c (Scheme 2) via a cyclo-
condensation with acetylacetone in moderate yields and high purity. The molecular 
structure of 5a was confirmed by X-ray crystal structure analysis.[8] The lithiation of 
5a at !78 °C using one equiv. of nbutyllithium and the addition of 0.5 equiv. of 
[IrCl(cod)]2 (cod = 1,5-cyclooctadiene), afforded 6a as a dark green crystalline 
material in moderate yield (Scheme 3). 
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Scheme 2: Ring transformation with (pyridylmethyl)amines [R = C6H5 (1a), R = tbutyl 
(1b); R = C6H5, Y = N, X = C (2a-5a); R = tbutyl, Y = N, X = C (2b-5b); R = C6H5, Y = 
C, X = N (2c-5c)].  
Scheme 3: Synthesis of iridium complexes 6a-c [R = C6H5, Y = N, X = C (5a/6a); R = 
tbutyl, Y = N, X = C (5b/6b); R = C6H5, Y = C, X = N (5c/6c)] and molecular structure of 
6a. Selected bond lengths [Å] and angles [°]: Ir1-N1 2.143(3), Ir1-N4 2.050(3), C1-N2 
1.360(4), C1-N3 1.341(5), C1-N4 1.351(5), N1-N2 1.393(4); N1-Ir1-N4 80.61(11), Ir1-
N1-N2 106.87(19), C1-N2-N1 121.50(3). 
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An X-ray crystal structure analysis[9] of 6a was performed to determine the molecular 
structure (Scheme 3). The monoanionic ligand coordinates the iridium atom via the 
amido N atom (N4) and N1, forming a five-membered chelate. Since the Ir1-N4 bond 
(2.050 Å) is significantly shorter than the Ir1-N1 bond (2.143 Å), we propose that the 
anionic charge of the ligand is localized at the amido N atom. The standard deviation 
of the imidazopyridazine plane is 0.010 Å. The deviation of the Namido atom out of this 
plane is 0.043 Å and for Ir it is 0.054 Å. The 2-pyridylmethyl moiety is bent out of the 
imidazopyridazine plane (N4-C15-C16 116.6°) and coordination by the pyridine 
nitrogen does not occur. The NMR spectra of 6a show a single signal set of 
deprotonated 5a and a double-coordinated cod ligand. 
While compound 6a is stable as a solid, in solution we observed the formation of the 
orange-red crystalline material 7a (Scheme 4) after a few weeks at room 
temperature. We were able to synthesize 7a in moderate yields through the reaction 
of 5a with 0.5 equiv. of [IrOCH3(cod)]2[10]. The resulting green solution was heated at 
50 °C for 2 weeks and the precipitated red crystalline material isolated (30%). An X-
ray crystal structure analysis[11] of 7a (Figure 1) revealed that intermolecular C-C 
bond formation between the 2-pyridylmethyl-substituents of two amido-ligands had 
occurred.  
Scheme 4: Evolution of C-C coupled dimers 7a and 7b. A dashed line highlights the 
newly formed C-C bond. 
The two imidazopyridazine planes of 7a are orientated nearly parallel (dihedral angle 
2.24°) to each other. The deviation of the Namido atom out of this plane (0.085 Å for 
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N7 and 0.113 Å for N2) is larger than in 6a, which is due to the altered coordination 
mode. In contrast to 6a, the iridium in 7a is coordinated by the Namido atom and the 
Npyridine via a five-membered chelate, leading to smaller N-Ir-N angles than in 6a of 
78.7° (N7-Ir2-N6) and 79.5° (N2-Ir1-N1), respectively. The Ir-N bond lengths of 2.019 
(Ir2-N7), 2.084 (Ir2-N6), 2.013 (Ir1-N2) and 2.088 (Ir1-N1) Å indicate a rather 
localized bonding mode. No solution NMR data could be obtained for 7a, since it is 
insoluble in common solvents. MAS-NMR data are in accordance with the signals 
expected for the C-C-coupled deprotonated ligand and cod. 
Figure 1: The molecular structures of 7a and 7b; selected bond lengths [Å] and angles 
[°]: 7a (the asymmetric unit contained two independent molecules of 7a, one molecule 
is omitted for clarity): Ir1-N1 2.088(8), Ir1-N2 2.013 (8), Ir2-N6 2.084(8), Ir2-N7 
2.019(8), C14-C15 1.589(11), C14-N2 1.448(13), C15-N7 1.432(13); N2-Ir-1-N1 
79.5(3), N7-Ir2-N6 78.7(3), N2-C14-C15 111.7(8), N7-C15-C14 112.2(7), C14-N2-Ir1 
115.6(6), C15-N7-Ir2 117.2(6); 7b: Ir1-N1 2.084(5), Ir2-N6 2.090(4), Ir1-N2 1.992(6), 
Ir2-N7 1.983(7), C15-N7 1.447(8), C14-N2 1.468(8), C14-C15 1.597(8); N2-Ir1-N1 
79.1(2), N7-Ir2-N6 79.0(2), C14-N2-Ir2 117.4(3), C6-N2-Ir2 117.7(5), N2-C14-C15 
112.4(5), N7-C15-C14 112.0(5). 
Due to the insolubility of 7a, we were interested in synthesizing a more soluble 
derivative, namely tbutyl-substituted 7b. When we tried to synthesize 6b via salt 
metathesis from lithiated 5b and [Ir(cod)Cl]2 using the same protocol as for 6a, we 
observed that C-C coupling took place more rapidly. Thus, we chose an alcohol 
elimination reaction. The addition of 0.5 equiv. of [IrOCH3(cod)]2 to a solution of 5b in 
THF gave rise to a dark green material 6b in quantitative yield (Scheme 3). The NMR 
spectra show a single signal set for deprotonated 5b and the signals for a double-
coordinated cyclooctadiene. The C-C coupling product 7b was isolated in moderate 
yield (28%) using the same protocol as for 7a (Scheme 4). An X-ray crystal structure 
analysis[12] of 7b was performed to determine its molecular structure (Figure 1). The 
bond length of the new C-C bond (C14-C15) is 1.597 Å. Due to the bulky tbutyl 
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substituents, the dihedral angle between these planes is extended to 24.84° (2.24° in 
7a). This also has an effect on the deviation of the Namido atom out of the 
imidazopyridazine plane (0.252 Å for N2 and 0.055 Å for N7). The iridium is 
coordinated by the Namido and the Npyridine via a five-membered chelate, resulting in N-
Ir-N angles of 78.99° (N7-Ir2-N6) and 79.09° (N2-Ir1-N1). Since the Ir-Namido bond 
lengths of 1.984 Å (N7-Ir2) and 1.991 Å (N2-Ir1) are similar to the Ir-Npyridine bond 
lengths (2.090 Å (N6-Ir2); 2.085 Å (N1-Ir1)), the bonding mode is localized. The NMR 
spectra of 7b show a single signal set for the deprotonated ligand and two double-
coordinated cyclooctadiene molecules. The new CH group, which was formed due to 
the C-C coupling, is characterized as a doublet (1H NMR) at 5.75 ppm with a 
coupling constant of 4.7 Hz. 
Regarding C-C coupling reactions with pyridines, the reactivity of the carbon atom 
can arise from the enamine tautomer. This is reinforced by the fact that pyridines (or 
unsubstituted aromatics), which are unable to tautomerize into enamines, do not 
participate in the reactions.[13]  
Therefore, we additionally synthesized the (3-pyridylmethyl)amine derivative of ligand 
5c; herein, the formation of an enamine tautomer is not possible. Complex 6c was 
obtained via salt metathesis upon deprotonation with nBuLi. Since the formation of a 
C-C coupling product could not be detected via NMR for 6c, we propose a coupling 
mechanism based on the formation of the enamine tautomer, followed by an 
intermolecular attack of the carbon atom next to the pyridine moiety (Scheme 5). The 
altered coordination mode in 7 cannot be realized in ligand 5c, which might 
additionally hinder the C-C coupling reaction.  
The iridium is thought to mediate the reaction via activation of the enamine and 
hydride transfer, thereby generating molecular hydrogen. Hydrogen evolution could 
be detected via NMR studies; a small singlet appeared at 4.21 ppm ([d8]THF). 
Scheme 5: The proposed mechanism based on tautomerization into an enamine and 
iridium-mediated hydride transfer. 
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Regarding the mechanism, double C-H activation followed by an intermolecular 
dehydrogenative C-C coupling reaction of the two iridium complexes 6a and 6b 
cannot be ruled out completely. The addition of a radical scavenger does not inhibit 
the formation of dimer 7b and does not decrease the rate of dimer formation 
significantly. Thus, radical-based C-C coupling reactions are not very likely. 
The reaction does not proceed completely, yielding only 19% of 7b in 24 h and about 
35% in 8 days. 
The closest reactivity pattern we could find is the coupling reaction of zinc complexes 
of N-substituted (2-pyridylmethyl)amines via oxidative pathways due to addition of 
white phosphorous or dimethylzinc by Westerhausen et al.. Since no radicals were 
observed by ESR, they propose that the reaction is strongly based on the redox 
potential of the metal, and that the driving force of the reaction is the regeneration of 
aromaticity after metalation of the methylene group and charge migration to the 
pyridine nitrogen.[14] 
4.3 Conclusions 
In conclusion, imidazo[1,5-b]pyridazine-substituted (pyridylmethyl)amines can be 
synthesized via the nucleophilic ring transformation of oxadiazolium halides 1 with 
(2/3-pyridylmethyl)amine, followed by deacetylation and cyclocondensation with 1,3-
diketones, in moderate yields and high purity. The deprotonated amines can act as 
amido-ligands, binding transition metals as five-membered chelates via the amido N-
atom and N-1 of the imidazopyridazine. 
An unusual intermolecular C-C coupling reaction for (2-pyridylmethyl)amine derived 
complexes 6a and 6b takes place in solution, giving rise to dinuclear complexes 7. 
We have proposed a mechanism based on enamine tautomerization, and 
intermolecular attack accompanied by iridium-mediated activation and hydride 
transfer, thereby evolving molecular hydrogen. 
4.4 Experimental Section 
4.4.1 General procedures  
Syntheses of the starting materials and ligands were performed under standard 
conditions. Complex syntheses were conducted in an oven (95 °C) and in vacuum 
dried glassware under an inert atmosphere of dry argon 5.0 via standard Schlenk or 
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glove box techniques. NMR spectra were recorded on a Bruker ARX 250/300 (250 or 
300 MHz) or a Varian Inova 300/400 (300/400 MHz) NMR spectrometer. Chemical 
shifts are reported in ppm from tetramethylsilane, with the solvent resonance 
resulting from incomplete deuteration as the internal standard. Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = 
broad, m = multiplet or combinations thereof), integration and coupling constant. 
Mass spectra were recorded on a Finnigan MAT 8500 spectrometer via electron 
ionization (70 eV). Melting points were determined in sealed capillaries by using a 
Stuart SMP3 melting point apparatus. Elemental analysis was performed with a Vario 
Elementar EL III or Leco CHN-932 elemental analyzer. Non-halogenated solvents 
were distilled from sodium benzophenone ketyl and halogenated solvents from P2O5. 
Deuterated solvents were obtained from Cambridge Isotope Laboratories and were 
degassed, dried and distilled prior to use. All chemicals were purchased from 
commercial vendors and used without further purification. 
4.4.2 Ligand Synthesis 
N-{4-phenyl-2-[(pyridin-2-ylmethyl)-amino]imidazo-1-yl}acetamide monohydrate 2a: 
2.00 g (6.71 mmol) 2-amino-5-methyl-3-phenacyl-1,3,4-oxadiazoliumbromide and 
1.37 mL (1.45 g; 13.43 mmol) (2-pyridylmethyl)amine were stirred for 1 min on a hot 
plate (250 °C). Then, the reaction mixture was allowed to cool to room temperature. 
Water (20 mL) was added and colorless crystals formed after several hours. After 
recrystallization from ethanol-water (1 : 1 ratio) 2a (1.95 g, 89%) was obtained. M.p. 
180 °C (decomposition). Found: C, 62.3; H, 5.7; N, 21.5. Calc. for C17H7N5O2 (307.33 
+ 18.02): C, 62.8; H, 5.9; N, 21.5%. !H (400.13 MHz, [d6]DMSO, 298 K, TMS) 10.94 
(s, 1H, NH, acetylamino), 8.58–8.56 (m, 1H, pyridine), 7.80-7.15 (m, 8H, 
C6H5/pyridine), 7.23 (s, 1H, H-5, imidazole), 6.77-6.74 (t, 1H, NH-CH2, J = 6.1), 4.66-
4.65 (d, 2H, CH2-NH, J = 6.1) and 2.08 (s, 3H, CH3); !C (100.63 MHz, [d6]DMSO, 298 
K, TMS) 169.53 (C O), 160.34 (C-2’’, pyridine), 149.43 (C-2, imidazole), 148.97 (C-
6’’, pyridine), 136.82 (C-4’’, pyridine), 135.12 (C-1’, C6H5), 133.85 (C-4, imidazole), 
128.57, 124.08 (Co,m, C6H5), 125.99 (Cp, C6H5), 122.23 (C-3’’, pyridine), 121.28 (C-
5’’, pyridine), 112.60 (C-5, imidazole), 47.87 (CH2) and 21.16 (CH3); m/z = 307 (M+), 
249, 118, 93 and 43.  
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4-phenyl-N2-pyridin-2-ylmethyl-imidazol-1,2-diamine dihydrochloride dihydrate 3a: To 
a suspension of 3.00 g (9.22 mmol) of 2a in 20 mL ethanol, 2 mL of concentrated HCl 
was added. The reaction mixture was refluxed for 1 h, during which a precipitate was 
formed after 30 min. After cooling to room temperature and evaporation of the 
solvent, the colorless product was recrystallized from water-ethanol (1 : 4 ratio) to 
yield 3a (2.17 g, 63%). Found: C, 48.1; H, 5.8; N, 18.7. Calc. for C15H21N5O2Cl2 
(265.31 + 36.03 + 72.90): C, 48.1; H, 5.7; N, 18.7%. !H (400.13 MHz, [d6]DMSO, 298 
K, TMS) 8.91-8.89 (m, 1H, H-6’’, pyridine), 8.71-8.68 (t, 1H, NH-CH2, J = 5.9), 8.39-
7.48 (m, 8H, C6H5/pyridine), 7.79 (s, 1H, H-5, imidazole) and 5.34-5.32 (d, 2H, CH2-
NH, J = 5.9); !C (100.63 MHz, [d6]DMSO, 298 K, TMS) 154.85 (C-2’’, pyridine), 
147.51 (C-2, imidazole), 144.64 (C-6’’, pyridine), 143.19 (C-4’’, pyridine), 135.63 (C-
1’, C6H5), 129.16, 125.13 (Co,m, C6H5), 128.47 (Cp, C6H5), 127.80 (C-4, imidazole), 
124.97, 124.10 (C-3’’, C-5’’, pyridine), 115.97 (C-5, imidazole) and 45.54 (CH2); m/z 
= 265 (M+), 249, 118, 93, 77 and 36.  
 
4-phenyl-N2-pyridin-2-ylmethyl-imidazol-1,2-diamine semihydrate 4a: 2.12 g (5.66 
mmol) of 3a was dissolved in water (10 mL) and 1 N NaOH was added until a weak 
basic reaction (pH 8) occurred. The white precipitate was washed with water and was 
recrystallized from water-ethanol (1 : 4 ratio) yielding 4a (1.55 g, 100%). M.p. 152 °C 
(decomposition). Found: C, 65.7; H, 5.9; N, 25.5. Calc. for C15H16N5O0.5 (265.31 + 
9.01): C, 65.6; H, 5.7; N, 25.2%. !H (400.13 MHz, CDCl3, 298 K, TMS) 8.72-8.70 (m, 
1H, H-6’’, pyridine), 7.94-7.23 (m, 8H, C6H5/pyridine), 7.32 (s, 1H, H-5, imidazole), 
6.36-6.33 (t, 1H, NH–CH2, J = 6.2), 5.83 (s, 2H, NH2) and 4.77-4.76 (d, 2H, CH2, J = 
6.2); !C (100.63 MHz, CDCl3, 298 K, TMS) 159.80 (C-2’’, pyridine), 150.01 (C-2, 
imidazole), 149.01 (C-6’’, pyridine), 136.86 (C-4’’, pyridine), 135.67 (C-1’, C6H5), 
132.79 (C-4, imidazole), 128.2, 123.87 (Co,m, C6H5), 125.52 (Cp, C6H5), 122.31, 
121.67 (C-3’’, C-5’’, pyridine), 113.83 (C-5, imidazole) and 48.14 (CH2).  
 
(2,4-dimethyl-5-phenyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine 5a: To a 
suspension of 1.10 g (4.01 mmol) of 4a in 7 mL glacial acetic acid, 0.40 g (0.41 mL; 
4.01 mmol) acetylacetone was added. The reaction mixture was refluxed for 2 h. 
Afterwards, the solvent was evaporated and 20 mL of water was added. After a few 
days, orange needles were obtained. Recrystallization from water-ethanol (1 : 2 ratio) 
yielded 5a (0.55 g, 42%). M.p. 110 °C. Found: C, 73.2; H, 5.8; N, 21.4. Calc. for 
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C20H19N5 (329.39): C, 72.9; H, 5.8; N, 21.3%. !H (400.13 MHz, CDCl3, 298 K, TMS) 
8.51-8.50 (d, 1H, H-6’’, pyridine), 7.57-7.06 (m, 8H, C6H5/pyridine), 5.82-5.81 (d, 1H, 
H-3, imidazopyridazine, J = 1.2), 5.76-5.73 (t, 1H, NH-CH2, J = 5.8), 4.84-4.82 (d, 2H, 
CH2-NH, J = 5.8), 2.23 (s, 3H, CH3-C-2) and 2.08-2.07 (d, 3H, CH3-C-4, 4J = 1.2); !C 
(100.61 MHz, CDCl3, 298 K, TMS) 158.59 (C-2’’, pyridine), 152.00 (C-7, 
imidazopyridazine), 149.52 (C-6’’, pyridine), 143.68 (C-2, imidazopyridazine), 139.30 
(C-4, imidazopyridazine), 136.94 (C-4’’, pyridine), 136.44 (C-1’, C6H5), 130.70, 
128.24 (Co,m, C6H5), 128.91 (C-4a, imidazopyridazine), 127.38 (Cp, C6H5), 122.55, 
122.50 (C-3’’, C-5’’, pyridine), 118.18 (C-5, imidazopyridazine), 112.01 (C-3, 
imidazopyridazine), 48.14 (CH2), 21.85 (CH3-C-2) and 19.86 (CH3-C-4). 
  
The ligands’ synthesis was simplified for 5b and 5c by sparing the characterization 
and purification of the intermediates. 
 
(5-t-butyl-2,4-dimethyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine hydrate 
5b: 4.00 g (14.38 mmol) 2-amino-3-(3,3-dimethyl-2-oxo-butyl)-5-methyl-1,3,4-
oxadiazolium bromide and 3.23 mL (31.68 mmol; 3.42 g) (2-pyridylmethyl)amine 
were stirred for 1 min on a hot plate (250 °C) and allowed to cool to room 
temperature. Next, the reaction mixture was extracted with CHCl3 (20 mL) to 
separate the insoluble (2-pyridylmethyl)amine hydrobromide by-product. After 
filtration, the solvent was evaporated, the residue was dissolved in 20 mL of ethanol, 
and 1.49 mL (1.44 g; 14.38 mmol) acetylacetone and 2 mL concentrated HCl were 
added. After refluxing the orange solution for 2 h, the solvent was evaporated, the 
red-orange product was dissolved in water (20 mL) and filtered. Then, 1 N NaOH was 
added to the filtrate until a weak basic reaction was observed and no more product 
precipitated. Afterwards, the red viscid product 5b (1.10 g, 25%) was dried in vacuo. 
Found: C, 65.75; H, 7.2; N 21.85. Calc. for C18H25N5O (309.41 + 18.02): C, 65.9; H, 
7.7; N 21.4%. !H (250.13 MHz, CDCl3, 298 K, TMS) 8.47-8.44 (d, 1H, H-6’’, pyridine, 
J = 4.9), 7.51-7.47 (t, 1H, H-5’’, pyridine, J = 7.7), 7.36-7.33 (d, 1H, H-3’’, pyridine, J 
= 7.8), 7.07-7.04 (m, 1H, H-4’’, pyridine), 5.71-5.70 (d, 1H, H-3, imidazopyridazine, 4J 
= 1.1), 5.43-5.38 (t, 1H, NH-CH2, J = 6.2), 4.75-4.72 (d, 2H, CH2-NH, J = 6.2 Hz), 
2.43-2.32 (d, 3H, CH3-C-4, 4J = 1.1), 2.13 (s, 3H, CH3-C-2) and 1.32 (s, 9H, 
C(CH3)3); !C (62.89 MHz, CDCl3, 298 K, TMS) 158.91 (C-2’’, pyridine), 150.45 (C-7, 
imidazopyridazine), 148.88 (C-6’’, pyridine), 140.63 (C-2, imidazopyridazine), 138.16 
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(C-4, imidazopyridazine), 137.81 (C-4a, imidazopyridazine), 136.25 (C-4’’, pyridine), 
122.11, 121.83 (C-3’’, C-5’’, pyridine), 116.37 (C-5, imidazopyridazine), 110.34 (C-3, 
imidazopyridazine), 48.31 (CH2), 33.00 (C(CH3)3), 32.24 (C(CH3)3), 23.09 (CH3-C-4) 
and 20.95 (CH3-C-2); m/z = 309 (M+), 294, 218, 203, 93, 65 and 41.  
 
(2,4-dimethyl-5-phenyl-imidazo[1,5-b]pyridazin-7-yl)-pyridin-3-ylmethyl-amine 5c:  
2.50 g (8.39 mmol) 2-amino-5-methyl-3-phenacyl-1,3,4-oxadiazolium bromide and 
1.88 mL (2.0 g; 18.46 mmol) (3-pyridylmethyl)amine were stirred for 1 min on a hot 
plate (250 °C) and allowed to cool to room temperature. Next, water was added and 
the white precipitate recrystallized from water-ethanol (1 : 2). 3.00 g (9.76 mmol) N-
{4-phenyl-2-[(pyridin-3-ylmethyl)amino]imidazo-1-yl}acetamide was dissolved in 10 
mL of ethanol and 2–3 mL concentrated HCl was added. The solution was refluxed 
for 1 h and afterwards the solvent was evaporated. The residue was dissolved in 
water and 1 N NaOH was added until a weak basic reaction occurred and no more 
product precipitated. The white product was filtered off and dried. To a suspension of 
1.48 g (5.58 mmol) 4-phenyl-N2-pyridine-3-ylmethyl-imidazol-1,2-diamine in 7 mL 
glacial acetic acid was added 578 !L (5.58 mmol) acetylacetone and the reaction 
mixture refluxed for 2 h. Afterwards, the solvent was evaporated and 20 mL of water 
was added. After a few days, orange needles of 5c (0.66 g, 24%) were obtained. 
Found: C, 72.7; H, 6.05; N, 21.7. Calc. for C20H19N5 (329.39): C, 72.9; H, 5.8; N, 
21.3%. !H (250.13 MHz, CDCl3, 298 K, TMS) 8.65 (s, 1H, C-2’’, pyridine), 8.46-8.45 
(d, 1H, C-6’’, pyridine, J = 3.8), 7.75-7.62 (d, 1H, C-4’’, pyridine, J = 7.8), 7.52-7.40 
(d, 2H, Co C6H5, J = 7.0), 7.36-7.30 (m, 4 H, C-5’’, pyridine/C6H5), 5.86 (s, 1H, H-3, 
imidazopyridazine), 4.98-4.94 (t, 1H, NH, J = 5.8), 5.21-5.16 (d, 2H, CH2, J = 5.8), 
2.23 (s, 3H, CH3-C-2) and 2.12 (s, 3H, CH3-C-4); !C (75.39 MHz, CDCl3, 298 K, TMS) 
151.22 (C-7, imidazopyridazine), 148.87 (C-2’’, pyridine), 148.11 (C-6’’, pyridine), 
142.34 (C-2, imidazopyridazine), 138.53 (C-4, imidazopyridazine), 135.33 (C-3’’, 
pyridine), 135.20 (C-5’’, pyridine), 134.70 (C-1’, C6H5), 129.72, 127.36 (Co,m, C6H5), 
128.04 (C-4a, imidazopyridazine), 126.55 (Cp, C6H5), 122.92 (C-4’’, pyridine), 117.27 
(C-5, imidazopyridazine), 111.15 (C-3, imidazopyridazine), 44.20 (CH2), 20.86 (CH3-
C-2) and 18.94 (CH3-C-4).  
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4.4.3 Complex Synthesis 
Preparation of 6a: To an orange solution of 0.55 g (1.66 mmol) (2,4-dimethyl-5-
phenyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine 5a in THF (20 mL) were 
added carefully (at !78 °C) 1.0 mL (1.66 mmol) nbutyllithium (1.6 M in nhexane). The 
purple reaction mixture was stirred at !78 °C for another 30 min and was then 
allowed to warm to room temperature. At room temperature, an orange solution of 
0.56 g (0.83 mmol) chloro-1,5-cyclooctadiene iridium(I) dimer in THF (10 mL) was 
added. The green solution was stirred for 16 h. Next, the solvent was evaporated and 
the residue dissolved in toluene, filtered and washed with ether. A dark green 
crystalline product 6a (0.45 g, 44%) was obtained at !30 °C from the combined 
filtrates. Found: C, 53.2; H, 5.1; N, 10.7. Calc. for C28H30IrN5 (628.79): C, 53.5; H, 
4.8, N, 11.1%. !H (300.13 MHz, CD2Cl2, 298 K, TMS) 8.03-8.02 (d, 2H, H-6’’, 
pyridine, J = 5.5), 7.72-7.67 (t, 1H, pyridine, J = 7.7), 7.50-7.45 (t, 2H, C6H5, J = 8.0), 
7.35-7.21 (m, 3H, C6H5/pyridine), 7.12–7.10 (m, 2H, C6H5), 5.93, 5.90 (2 s, 1H, H-3, 
imidazopyridazine), 5.24, 5.22 (2s, 2H, CH2-NH), 3.97 (br s, 2H, CH, cod), 3.17 (br s, 
2H, CH, cod), 2.26 (s, 3H, CH3-C-2/4), 2.13 (s, 3H, CH3C-4/2), 2.25–2.09 (br m, 4H, 
CH2, cod) and 1.60–1.57 (br d, 4H, CH2, cod); !C (75.48 MHz, CD2Cl2, 298 K, TMS) 
146.60, 139.35, 137.22, 136.91, 134.38, 130.57, 130.42, 128.75, 128.04, 127.06, 
122.22, 121.07 (Co,m,p, C6H5, pyridine, imidazopyridazine), 118.64 (C-5, 
imidazopyridazine), 112.20, 111.93 (C-3, imidazopyridazine), 66.83 (4 x CH, cod), 
55.14 (CH2-N), 31.77 (4 x CH2, cod), 21.70, 21.31 (CH3-C-2/4) and 19.84 (CH3-C-
4/2). 
 
Preparation of 6b: To an orange solution of 0.20 g (0.65 mmol) (5-t-butyl-2,4-
dimethyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine 5b in THF (5 mL) was 
added a yellow solution of 0.21 g (0.32 mmol) 1,5-cyclooctadiene-methoxy iridium(I) 
dimer in THF (10 mL). The dark green solution was immediately concentrated to 
dryness in vacuo, yielding 6b (0.39 g, 100%). Found: C, 51.5; H, 6.1; N, 11.2. Calc. 
for C26H34IrN5 (608.80): C, 51.3; H, 5.6; N, 11.5%. !H (250.13 MHz, [d8]THF, 298 K, 
TMS) 8.15-8.13 (d, 1H, H-6’’, pyridine, J = 4.7), 7.59-7.53 (t, 1H, H-5’’, pyridine, J = 
7.4), 7.39-7.36 (d, 1H, H-3’’, pyridine, J = 7.8), 7.07-7.02 (t, 1H, H-4’’, pyridine, J = 
8.3), 5.76 (s, 1H, H-3, imidazopyridazine), 5.08 (s, 2H, CH2-N), 4.12 (br s, 2H, CH, 
cod), 3.55-3.49 (m, 2H, CH, cod), 2.49 (d, 3H, CH3-C-2), 2.22 (s, 3H, CH3-C-4), 2.03 
(br s, 4H, CH2, cod), 1.59 (br s, 4H, CH2, cod) and 1.24 (s, 9H, C(CH3)3); !C (75.39 
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MHz, C6D6, 298 K, TMS) 147.42, 139.91, 139.00, 136.33, 121.71, 121.18, 118.53 (C-
5, imidazopyridazine), 110.04 (C-3, imidazopyridazine), 68.15 (CH2-N), 57.04, 53.35, 
52.33 (CH cod), 34.78 (C(CH3)3), 32.77 (C(CH3)3), 32.46, 31.95, 26.17 (CH2 cod), 
23.22 (CH3-C-2) and 21.00 (CH3-C-4). Even though different solvents, such as C6D6, 
[d8]THF and CD2Cl2, were tested and up to 10 000 scans performed, not all of the 
quaternary C atoms could be detected.  
 
Preparation of 6c: To an orange solution of 0.56 g (1.70 mmol) (2,4-dimethyl-5-
phenyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-3-ylmethyl-amine 5c in THF (15 mL) was 
added carefully (at !78 °C) 1.06 mL (1.70 mmol) nbutyllithium (1.6 M in nhexane). 
The purple reaction mixture was stirred at !78 °C for another 30 min and then 
allowed to warm to room temperature. At room temperature, an orange solution of 
0.57 g (0.85 mmol) chloro-1,5-cyclooctadiene iridium(I) dimer in THF (10 mL) was 
added. The green solution was stirred for 16 h, the solvent was evaporated, and the 
residue was dissolved in toluene, filtered and washed with ether. From the combined 
filtrates in toluene, a dark green crystalline product 6c (0.33 g, 32%) was obtained at 
!30 °C. Found: C, 53.25; H, 5.3; N, 10.7. Calc. for C28H30IrN5 (628.79): C, 53.5; H, 
4.8; N 11.1%. !H (250.13 MHz, CDCl3, 298 K, TMS) 8.61 (s, 1H, pyridine), 8.41-8.39 
(d, 1H, pyridine, J = 4.3), 7.69-7.66 (d, 1H, pyridine, J = 5.5), 7.51-7.12 (m, 6H, 
pyridine, C6H5), 5.75 (s, 1H, H-3, imidazopyridazine), 4.95 (s, 2H, CH2), 4.41 (br s, 
2H, CH, cod), 4.08 (br s, 2H, CH, cod), 2.48 (s, 3H, CH3-C-2), 2.28 (s, 3H, CH3-C-4), 
2.33-2.16 (m, 4H, CH2, cod) and 1.82-1.61 (m, 4 H, CH2, cod); !C (62.89 MHz, 
CDCl3, 298 K, TMS) 160.41 (C-7, imidazopyridazine), 156.86 (C-3’’, pyridine), 
148.78, 147.52 (C-2’’, C-6’’, pyridine), 141.90 (C-2, imidazopyridazine), 138.11 (C-4’’, 
pyridine), 136.15 (C-1’, C6H5), 134.54 (C-5’’, pyridine), 130.02, 127.94 (Co,m, C6H5), 
128.98 (C-4a, imidazopyridazine), 127.52 (Cp, C6H5), 119.20 (C-5, 
imidazopyridazine), 110.17 (C-3, imidazopyridazine), 62.86, 53.12 (CH, cod), 46.03 
(CH2), 31.65, 30.40 (CH2, cod), 20.29 (CH3-C-2) and 19.03 (CH3-C-4). 
 
Preparation of 7a: Into a pressure tube containing an orange solution of 0.21 g (0.65 
mmol) (2,4-dimethyl-5-phenyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine 
5a in THF (10 mL) was added 0.21 g (0.32 mmol) 1,5-cyclooctadiene-methoxy 
iridium(I) dimer. The solution immediately changed its color to dark green. The 
solution was heated at 50 °C for several days, while its color changed to brown and 
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red crystals formed. The crystalline material 7a (0.12 g, 30%) was filtered off and 
washed three times with THF. Found: C, 53.2; H, 4.8; N, 10.8. Calc. for C56H58Ir2N10 
(1255.56): C, 53.6; H, 4.7; N, 11.2%. (7a is insoluble in all common solvents, such as 
methanol, isopropanol, CH2Cl2, THF, toluene, benzene and DMSO; due to this, no 
solution NMR data is available.) MAS solid state 13C NMR: !C 166.31, 149.78, 
148.29, 143.20, 137.02, 128.51, 122.91 (imidazopyridazine, pyridine, C6H5), 118.08 
(C-5, imidazopyridazine), 110.73 (C-3, imidazopyridazine), 75.37 (CH), 67.64, 63.00, 
54.69 (CH, cod), 32.85, 26.28 (CH2, cod) and 21.84 (CH3-C-2/4).  
 
Preparation of 7b: Into a pressure tube containing an orange solution of 0.20 g (0.65 
mmol) (5-t-butyl-2,4-dimethyl-imidazo[1,5-b]pyridazin-7-yl)pyridin-2-ylmethyl-amine 
5b in hexane (10 mL) was added 0.21 g (0.32 mmol) 1,5-cyclooctadiene-methoxy 
iridium(I) dimer. The solution immediately changed its color to dark green. After 
several weeks, a red crystalline material, 7b (0.11 g, 28%) was obtained. Found: C, 
51.2; H, 5.7; N, 11.2. Calc. for C52H66Ir2N10 (1215.58): C, 51.3; H, 5.5; N, 11.5%. !H 
(250.13 MHz, [d8]THF, 298 K, TMS) 9.38-9.35 (d, 1H, pyridine, J = 7.8), 8.14-8.11 (t, 
1H, pyridine, J = 8.3), 7.59-7.57 (d, 1H, pyridine, J = 5.6), 7.19–7.14 (t, 1H, pyridine, 
J = 7.1), 5.75–5.74 (m, 2H, CH-N, H-3, imidazopyridazine), 2.69 (m, 2H, CH cod), 
2.37–2.33 (m, 2H, CH cod), 2.59 (s, 3H, CH3-C-2/4), 1.79 (s, 3H, CH3-C-4/2), 1.99-
1.86 (m, 4H, CH2 cod), 1.49-1.28 (m, 4H, CH2 cod) and 1.53 (s, 9H, C(CH3)3); !C 
(62.89 MHz, [d8]THF, 298 K, TMS) 166.67, 148.12, 144.90, 136.04, 127.78 (C-7, C-
2, C-4, C-4a, imidazopyridazine; C-1’’, pyridine), 143.56, 134.74, 126.71, 121.46 
(pyridine), 116.59 (C-5, imidazopyridazine), 109.85 (C-3, imidazopyridazine), 74.88 
(CH), 65.56, 67.96, 54.03, 52.08 (CH, cod), 33.42, 33.11, 30.17, 28.82 (CH2, cod), 
32.71 (C(CH)3), 31.98 (C(CH)3), 22.40 and 20.55 (CH3-C-2/4). 
Supporting Information available 
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symmetry space group P21/n, monoclinic, a = 14.2110(6), b = 23.5720(10), c 
= 14.6060(6) Å, ß = 103.436(3)°, V = 4758.8(3) Å3, Z = 4, "cald. = 1.697 g/cm3, 
8987 reflections, 6493 independent reflections, R = 0.0361 [I > 2#(I)], wR2 (all 
data) = 0.0764, 587 parameters. CCDC-729912 contains the supplementary 
crystallographic data for this publication. 
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Abstract: Novel N,N,P-ligand stabilized rhodium complexes exhibiting high activities 
and enantioselectivities in the asymmetric hydrogenation of N-aryl imines are 
introduced. The ligands were synthesized from inexpensive starting materials and 
their modular design allows for the introduction of a broad variety of substitution 
patterns. Additionally, a rather low catalyst loading could be employed. 
5.1 Introduction  
Given that 80% of the pharmaceuticals in the product-pipeline are chiral and that the 
launch of enantiopure drugs will be facilitated, there is an increasing demand for 
chiral intermediates such as amines, alcohols or acids.[1] Asymmetric hydrogenation 
technologies, which are (atom)economic and easily upscalable, provide an excellent 
access to those substances.[2] During the last decade various enantioselective imine 
hydrogenation catalysts were introduced,[3-7] most of them being cationic iridium 
complexes based on neutral P,N- ligands, for instance phosphino-oxazolines or P,N- 
ferrocenyles.[3] Neutral ligands might be easier replaced by strongly coordinating 
substrates like imines and consequently we became interested in developing anionic 
ligands for the enantioselective hydrogenation of imines. 
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Recently, we introduced imidazo[1,5-b]pyridazine- substituted amido-ligands, which 
stabilize late and early transition metal complexes.[8] Chiral imidazo[1,5-b]pyridazine-
substituted amino alcohols 2 are of special interest therein. They can be synthesized 
in a one-pot approach via the nucleophilic ring transformation of oxadiazolium halides 
1 with amino alcohols followed by a cyclocondensation reaction with 1,3-diketones 
(Scheme 1).  
The resulting iridium amido-complexes exhibit good activities and excellent 
enantioselectivities in the asymmetric ketone hydrogenation.[9] 
Herein, the synthesis of novel imidazo[1,5-b]pyridazine-substituted amines 3 is 
reported. Upon deprotonation they act as monoanionic tridentate amido-ligands and 
are suitable for the stabilization of group 9 metal complexes. The chiral amido- 
complexes 4 show high efficiency and very good enantioselectivity in the asymmetric 
hydrogenation of imines.[10] 
Scheme 1: One-pot synthesis of 2. 
5.2 Results and Discussion 
The novel amines 3 can be synthesized via P-functionalization of 2 in good to 
excellent yields and high purities (Scheme 2). Lithiation with nBuLi selectively occurs 
at the O-atom of the hydroxyl group. Subsequently one equivalent of dialkyl-, diaryl-
chlorophosphine or ethylene chlorophosphite is added, giving rise to 3a-h as orange 
viscous products.  
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Scheme 2: Synthesis of 3a-h (3a: R2=iBu, R5=Ph; 3b: R2=iBu, R5=iPr; 3c: R2=iBu, 
R5!R5= OCH2-CH2O; 3d: R2=Me, R5=iPr; 3e: R2=Bn, R5=iPr; 3f: R2=iBu, R5=Et; 3g: 
R2=iBu, R5=tBu; 3h: R2=iBu, R5=Cy). 
The amido-complexes 4a-j can be obtained via alcohol elimination route with 
[MOCH3(cod)]2[11] (M=Ir, Rh) (Scheme 3). Addition of 0.5 equiv. of the metal 
precursor to a solution of 3a-h in THF gives rise to 4a-j, which is accompanied by a 
color change to blue/green. The NMR spectra show a single signal set for the 
deprotonated ligand and 1,5-cyclooctadiene. The Rh(I)-P-coupling constant of 158.40 
Hz (4a) is in accordance with the literature.[12] 
Scheme 3: Synthesis of amido-complexes 4a-j (M=Rh: 4a: R2=iBu, R5=Ph; 4b: 
R2=iBu, R5=iPr; 4c: R2=iBu, R5!R5= OCH2-CH2O; 4d: R2=Me, R5=iPr; 4e: R2=Bn, 
R5=iPr; 4f: R2=iBu, R5=Et; 4g: R2=iBu, R5=tBu; 4h: R2=iBu, R5=Cy; M=Ir: 4i: R2=iBu, 
R5=iPr; 4j: R2=iBu, R5!R5= OCH2-CH2O).  
Figure 1. Molecular structure of 4a; selected bond lengths [Å] and -angles [°]: N4-Rh1 
2.233(2), N1-Rh1 2.349(2), P1-Rh1 2.2423(8), O1-P1 1.608(2); N1-Rh1-N4 74.02(8), 
N4-Rh1-P1 79.67(7), N2-N1-Rh1 107.84(16), C9-N4-Rh1 113.83(18), O1-P1-Rh1 
112.30(8). 
+ 0.5 [MOCH3(cod)]2
- CH3OH
3a-h N
N
N N O
P
R5
R5
M
4a-j
R2 M= Ir, Rh
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An X-ray crystal structure analysis of 4a was performed to determine the molecular 
structure (Figure 1). The monoanionic ligand coordinates the Rh-atom via a five-
membered chelate (Rh, N4, C9, N2, N1). The complex is further stabilized by 
coordination of the P-atom (P1-Rh1). Since the N4-Rh1 bond length of 2.233 Å is 
significantly shorter than the N1-Rh1 bond length (2.350 Å), the anionic charge of the 
ligand is localized at the amido-N-atom. The phenyl substituents of the P-atom are 
orientated 93.16° to each other and point away from the imidazopyridazine plane. 
Complexes 4b-c (Rh) and 4i-j (Ir) (Scheme 3) were utilized for the asymmetric 
hydrogenation of N-(1-phenylethylidene)aniline 5a at 40 °C and 60 bar H2-pressure 
(Table 1). Herein, the dialkyl-phosphine- substituted rhodium amido-complex 4b was 
the most promising catalyst system. Upon addition of KOtBu complete conversion 
and 82% ee could be achieved in 24 h with a catalyst loading of only 0.1 mol%. 
Table 1: Results of the asymmetric hydrogenation of 5a with 4. 
No. Catalyst Base Yield[a] [%] ee[b] [%] 
1 4b - 0 - 
2 4b KOtBu >99 82 
3 4c - 46 rac 
4 4c KOtBu 41 21 
5 4i - 0 - 
6 4i KOtBu 37 17 
7 4j - 0 - 
8 4j KOtBu 98 30 
0.1 mol% 4, 24 h, 40 °C, 60 bar H2; [a] determined via GC; [b] determined via HPLC 
The selectivity in the asymmetric hydrogenation of 5a with 4b could be increased 
from 82% (40°C, 60 bar) to 90% (rt, 20 bar) by optimization of the reaction 
conditions. A pressure dependence of the selectivity was not observed (5-60 bar). 
The addition of an excess of KOtBu (see Supporting Information) generates the best 
activity and enantioselectivity. 
Due to the modular design of 4, the steric and electronic properties of the ligand can 
easily be fine tuned towards the substrate. Herein the influence of amino alcohol- and 
P-substituents on the activity and enatioselectivity was investigated (Table 2). The 
combination of electron-donating phosphine substituents (iPr, Cy) and amino 
alcohols (iBu) gave the best results in the hydrogenation of 5a (Table 2, entry: 2, 7). 
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Table 2: Catalyst screening for the hydrogenation of 5a with 0.1 mol% 4. 
No. Catalyst Yield[a] [%] ee[b] [%] 
1 4a 62 70 
2 4b >99 90 
3 4d 79 81 
4 4e 63 84 
5 4f 85 85 
6 4g 88 86 
7 4h 96 90 
KOtBu, 24 h, 20 °C, 20 bar H2; [a] determined via GC; [b] determined via HPLC 
Table 3: Hydrogenation of N-aryl imines with 4b. 
 
 
 
No. Imine Yield[a] [%] ee[b] [%] Lit. ee [%] 
1# 5a 
 
>99 90 95[4e] 
2 5b 
 
97 86 94[3f] 
3 5c 
 
>99 82 97[4e] 
4 5d 
 
>99 89 91[3f] 
5*# 5e 
 
98 90 99[4d] 
6 5f 
 
>99 87 no data 
7# 5g 
 
>99 75 97[4e] 
8# 5h 
 
>99 83 no data 
9 5i 
 
>99 76 78[3e] 
10*# 5j 
 
>99 74 no data 
11* 5k 
 
>99 57 no data 
0.1 mol% (*0.2 mol%) 4b, KOtBu, 48 h (#24 h), rt, 20 bar H2; [a] determined via GC; [b] determined via HPLC. 
[3e]0.5 mol% Ir-complex, 25°C, 20 bar H2. [3f]1 mol% Ir-complex, 10°C, 1 bar H2.[4d]1 mol% [Ir(cod)2]BArF, 2 mol% (S)-PipPhos, rt, 
1 bar H2. [4e]1mol% Ir-complex, 20°C, 20 bar H2. 
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High enantioselectivities, which are similar to the best known literature 
systems[4d,e;3e,f], could be obtained in the asymmetric hydrogenation of various N-aryl 
imines 5 with 4b (Table 3). 
Due to the anionic nature of the supporting ligand a higher hydrogenation efficiency 
in comparison to most of these literature systems was observed. The catalyst loading 
could be reduced to 0.1-0.2 mol% (typically 1 mol% in the literature). 
The high efficiency and enantioselectivity could furthermore be verified in a 
preparative experiment. Therein 2.5 g of 5a was isolated (83% yield and 89% ee). 
5.3 Conclusions 
In conclusion the reported amido-complexes represent a novel class of efficient and 
easily accessible catalysts for the asymmetric hydrogenation of imines. Due to the 
modular ligand design, broad substitution patterns can be realized. The high 
efficiency and good selectivity combined with the novel structural motif opens up new 
prospects for the enantioselective hydrogenation of imines. 
5.4 Experimental Section 
5.4.1 General Procedure for the asymmetric hydrogenation 
Stock solutions of the pre-catalysts (3.01 µmol/mL) were prepared in THF via alcohol 
elimination reaction of the ligand (stock solution in THF) and 0.5 equiv. of 
[MOCH3(cod)]2 (M= Rh, Ir). Stock solutions of the imines (1.51 mmol/mL) were 
prepared in THF. The solutions were prepared and stored in a glove box. A high-
pressure steel autoclave (Parr Instruments; 300 mL, 200bar, 350 °C) with an 
aluminum insert for multiple reaction tubes (5 or 20) was taken into a glove box. Then 
the reaction tube (placed in a 20- or 5-well insert for the autoclave, equipped with a 
magnetic stir bar) was loaded with additive (base if required), the pre-catalyst-
solution (e.g. 200µL = 0.1 mol%) and 400 µL (0.60 mmol) of the substrate solution. 
Then the autoclave was sealed and taken out of the glove box. The autoclave was 
attached to a high-pressure hydrogen line and purged with H2. The autoclave was 
sealed under the appropriate H2 pressure and the mixture was stirred for e.g. 24 h at 
the appropriate pressure at room temperature or at the appropriate temperature 
(external heating mantle). In order to stop the hydrogenation reaction, the pressure 
was released and water and dodecane (standard for GC) were added to the reaction 
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solution. The samples were extracted with diethyl ether (3 mL) and the organic phase 
was centrifugalized at 12.000 rpm and filtered through 0.2 µm PTFE-syringe filters. 
This solution was directly used for determination of the conversion (GC, Lipodex E or 
Chirasil-DEX column). For HPLC (Chiralpak IB column) purposes the samples were 
diluted (40x) with diethyl ether (determination of ee). 
Supporting Information available 
Supporting information including detailed experimental section and crystallographic 
data is available (Refer to 5.6). 
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5.6 Supporting Information 
5.6.1 General  
Syntheses of the starting materials and ligands were performed under standard 
conditions. Complex syntheses were conducted in oven (95 °C) and in vacuum dried 
glassware under an inert atmosphere of dry argon 5.0 via standard Schlenk or glove 
box techniques. NMR spectra were recorded on a Bruker ARX 250 (250 MHz) or on 
a Varian Inova 300/400 (300 or 400 MHz) NMR-spectrometer. Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance resulting from 
incomplete deuteration as the internal standard. Data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, 
m = multiplet or combinations thereof), integration and coupling constant. Elemental 
analysis was performed with a Vario elementar EL III elemental analyzer. Non-
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halogenated solvents were distilled from sodium benzophenone ketyl and 
halogenated solvents from P2O5. Deuterated solvents were obtained from Cambridge 
Isotope Laboratories and were degassed, dried and distilled prior to use. All 
chemicals were purchased from commercial vendors and used without further 
purification.  
5.6.2 Ligand Synthesis 
N-(1-((diphenylphosphino)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3a: 0.87 g (2.57 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo 
and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 1.61 mL (2.57 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.48 
mL (2.57 mmol) of chlorodiphenylphosphine was added and the solution was stirred 
for 12 h at room temperature (color changes again to orange). The orange solution 
was evaporated to dryness and the orange residue was extracted with 15 mL of 
diethyl ether (2x), the combined filtrates were evaporated to dryness yielding 3a (0.78 
g, 58%) as an orange viscous product. Found:  C, 72.6; H, 7.7; N, 9.2. Calc. for 
C32H35N4OP*C4H8O (522.62 + 72.11): C, 72.7; H 7.3; N 9.4%. !H (250.13 MHz, 
CD2Cl2, 298 K, TMS) 7.50-7.25 (m, 15H, 3 x C6H5), 5.95-5.94 (d, 1H, H-3, 
imidazopyridazine, J = 1.2), 4.84-4.81 (d, 1H, NH, J = 9.5), 4.40-4.28 (m, 1H, HN-
CH), 4.11-3.93 (m, 2H, CH2O), 2.31 (s, 3H, CH3-C-2), 2.20-2.19 (d, 3H, CH3-C-4, J = 
1.1), 1.85-1.48 (m, 3H, CH2CH(CH3)2) and 0.98-0.95 (dd, 6H, CH(CH3)2), J =  6.6, 
1.4); !C (62.90 MHz, CD2Cl2, 298 K, TMS) 151.81 (C-7, imidazopyridazine), 143.29 
(C-2, imidazopyridazine), 139.19 (C-4, imidazopyridazine), 130.62, 130.61, 130.51, 
130.27, 129.49, 129.45, 128.59, 128.49, 128.03, 127.08 (C-4a, imidazopyridazine, 3 
x C6H5), 117.81 (C-5, imidazopyridazine), 111.67 (C-3, Imidazopyridazine), 72.41, 
72.14 (CH2O), 68.13 (THF), 52.39, 52.26 (CH-NH), 41.72 (CHCH2CH), 25.96 (THF), 
25.28 (CH(CH3)2), 23.33, 22.48 (CH(CH3)2), 21.58 (CH3-C-2) and 19.68(CH3-C-4); !P 
(101.26 MHz, CD2Cl2, 298 K, TMS) 113.19. 
 
N-(1-((diisopropylphosphino)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3b: 1.00 g (2.95 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo 
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and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 1.84 mL (2.95 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.47 
mL (2.95 mmol) of chlorodiisopropylphosphine was added and the solution was 
stirred for 12 h at room temperature (color changes again to orange). The orange 
solution was evaporated to dryness and the orange residue was extracted with 15 
mL of hexane (2x), the combined filtrates were evaporated to dryness yielding 3b 
(1.19 g, 89%) as an orange viscous product. Found: C, 69.6; H, 9.7; N, 11.75. Calc. 
for C26H39N4OP*0.5 C6H14 (454.59 + 43.09): C, 69.9; H 9.3; N, 11.3%. !H (299.83 
MHz, C6D6, 298 K, TMS) 7.47-7.45 (d, 2H, C6H5, J = 8.4), 6.99-6.94  (t, 2H, C6H5, J = 
7.8), 6.86-6.83 (m, 1H, C6H5), 5.01-5.01 (d, 1H, H-3, imidazopyridazine, J = 0.6), 
4.81-4.77 (d, 1H, NH, J = 9.3), 4.29-4.25 (m, 1H, CH-NH), 3.76-3.58 (m, 2H, CH2O), 
1.72 (s, 3H, CH3-C-2), 1.59 (s, 3H, CH3-C-4), 1.33-1.22 (m, 5H, CH2CH(CH3)2, 
P(CH(CH3)2)2), 0.91-0.80 (m, 6H, CH(CH3)2) and 0.73-0.60 (m, 12H, P(CH(CH3)2)2); 
!C (75.39 MHz, CDCl3, 298 K, TMS) 152.02 (C-7, imidazopyridazine), 143.91 (C-2, 
imidazopyridazine), 139.68 (C-4, imidazopyridazine), 137.09 (C1’, C6H5), 131.11, 
128.69 (Co,m, C6H5), 129.47 (C-4a, imidazopyridazine), 127.66 (Cp, C6H5), 118.26 (C-
5, imidazopyridazine), 112.01 (C-3, imidazopyridazine), 74.80, 74.58 (CH2O), 52.91, 
52.79 (CH-NH), 42.46 (CH2), 32.44 (CH2, hexane), 29.10, 29.08, 28.88, 28.86 
(P(CH(CH3)2)2), 25.80 (CH(CH3)2), 24.05, 23.49 (CH(CH3)2, hexane), 22.19 (CH3-C-
2), 20.33 (CH3-C-4), 18.99, 18.96, 18.72, 18.69, 17.90, 17.84, 17.79, 17.73 
(P(CH(CH3)2)2) and 14.98 (CH3 hexane); !P (121.37 MHz, CDCl3, 298 K, TMS) 
152.61. 
 
N-(1-((1,3,2-dioxaphospholan-2-yl)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3c: 0.57 g (1.68 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo 
and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 1.05 mL (1.68 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.15 
mL (1.68 mmol) of ethylene chlorophosphite was added and the solution was stirred 
for 12 h at room temperature (color changes again to orange). The orange solution 
was evaporated to dryness and the orange residue was extracted with 20 mL of 
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diethyl ether (2x), the combined filtrates were evaporated to dryness yielding 3c (0.58 
g, 81%) as an orange viscous product. Found:  C, 61.5; H, 7.2; N, 12.0. Calc. for 
C22H29N4O3P*0.5 C4H10O (428.46 + 37.06):  C, 61.9; H, 7.4; N, 12.0%. !H (250.13 
MHz, CD2Cl2, 298K, TMS) 7.47-7.43 (m, 2H, Ho, C6H5), 7.34-7.22 (m, 3H, Hm,p, 
C6H5), 5.89-5.88 (d, 1H, H-3, imidazopyridazine, J = 1.1); 4.86 (br s, 1H, NH), 4.25-
3.76 (m, 11H, THF/CH2O/O-CH2-CH2-O), 2.25 (s, 3H, CH3-C-2), 2.10-2.09 (d, 3H, 
CH3-C-4, J = 1.1), 1.62-1.36 (m, 7H, THF/CH2CH(CH3)2) and 0.88-0.84 (dd, 6H, 
CH(CH3)2, J = 3.2); !C (62.90 MHz, CD2Cl2, 298K, TMS) 151.97 (C-7, 
imidazopyridazine), 142.79 (C-2, imidazopyridazine), 139.05 (C-4, 
imidazopyridazine), 130.73 (C-1´, C6H5), 130.34, 127.91 (Co,m, C6H5), 128.17 (C-4a, 
imidazopyridazine), 127.09 (Cp, C6H5), 117.67 (C-5, imidazopyridazine), 111.85 (C-3, 
imidazopyridazine), 67.93 (THF), 65.20, 65.06 (CH2O), 64.58, 64.53, 64.44, 64.39 
(O-CH2-CH2-O), 51.41, 51.35 (CH-NH), 41.17 (CH-CH2-CH), 25.76 (THF), 24.99 
(CH(CH3)2), 23.13, 22.24 (CH(CH3)2),  21.39 (CH3-C-2) and 19.46 (CH3-C-4); !P 
(101.26 MHz, CD2Cl2, 298 K, TMS) 132.92. 
 
N-(1-((diisopropylphosphino)oxy)propan-2-yl)-2,4-dimethyl-5-phenylimidazo[1,5-
b]pyridazin-7-amine 3d: 1.00 g (3.37 mmol) of 2-((2,4-dimethyl-5-phenylimidazo[1,5-
b]pyridazin-7-yl)amino)propan-1-ol was dried in vacuo and dissolved in 30 mL of dry 
diethyl ether/THF (1:1). The orange solution was cooled to -78 °C, then 2.10 mL 
(3.37 mmol) of nBuLi (1.6 M in hexane) was added cautiously. Thereby, the solution 
changed its color to dark brown. The solution was stirred at -78 °C for another 30 
minutes and warmed to room temperature. Then 0.53 mL (3.37 mmol) of 
chlorodiisopropylphosphine was added and the solution was stirred for 12 h at room 
temperature (color changes again to orange). The orange solution was evaporated to 
dryness and the orange residue was extracted with 15 mL of hexane (2x), the 
combined filtrates were evaporated to dryness yielding 3d (1.17 g, 84%) as an 
orange viscous product. Found:  C, 66.9; H, 8.9; N, 11.8. Calc. for 
C23H33N4OP*C4H8O (412.51 + 72.11): C, 66.9; H, 8.5; N, 11.6%. !H (299.83 MHz, 
C6D6, 298 K, TMS) 7.57-7.54 (d, 2H, Ho, C6H5), 7.41-7.27 (m, 3H, Hm,p, C6H5), 5.91-
5.91 (d, 1H, H-3, imidazopyridazine, J = 0.9), 5.02-4.99 (d, 1H, NH, J = 8.7),  4.33-
4.28 (m, 1H, CH-NH), 3.93-3.78 (m, 2H, CH2O), 2.32 (s, 3H, CH3-C-2), 2.19-2.18 (d, 
3H, CH3-C-4, J = 0.9), 1.81-1.70 (m, 2H, P(CH(CH3)2)2), 1.41-1.39 (d, 3H, CH-CH3, J 
= 6.6) and 1.16-1.01 (m, 12H, P(CH(CH3)2)2); !C (75.39 MHz, C6D6, 298 K, TMS) 
151.24 (C-7, imidazopyridazine), 142.84 (C-2, imidazopyridazine), 138.82 (C-4, 
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imidazopyridazine), 136.14 (C-1’, C6H5), 130.24, 127.73 (Cm,o, C6H5), 128.63 (C-4a, 
imidazopyridazine), 126.82 (Cp, C6H5), 117.38 (C-5, imidazopyridazine), 111.22 (C-3, 
imidazopyridazine), 75.45, 75.22 (CH2O), 49.75, 49.64 (CH-NH), 28.26, 28.16, 28.04, 
27.94 (P(CH(CH3)2)2), 21.31 (CH3-C-2), 19.40 (CH3-C-4), 18.39 (CH-CH3) and 18.07, 
17.81, 16.91 (P(CH(CH3)2)2); !P (121.37 MHz, C6D6, 298 K, TMS) 153.42. 
 
N-(1-((diisopropylphosphino)oxy)-3-phenylpropan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3e: 0.60 g (1,61 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-3-phenylpropan-1-ol was dried in vacuo 
and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 1.00 mL (1.61 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.26 
mL (1.61 mmol) of chlorodiisopropylphosphine was added and the solution was 
stirred for 12 h at room temperature (color changes again to orange). The orange 
solution was evaporated to dryness and the orange residue was extracted with 15 
mL of hexane (2x), the combined filtrates were evaporated to dryness yielding 3e 
(0.71 g, 90%) as an orange viscous product. Found:  C, 70.4; H, 8.7; N, 10.0. Calc. 
for C29H37N4OP*C4H10O (488.60 + 74.12): C, 70.4; H, 8.4; N, 10.0%. !H (299.83 
MHz, C6D6, 298 K, TMS) 7.74-7.71 (m, 2H, Ho, C6H5), 7.31-6.97 (m, 8H, C6H5), 5.32-
5.30 (d, 1H, NH, J = 8.8), 5.32-5.30 (s, 1H, H-3, imidazopyridazine, J = 1.2), 4.65-
4.63 (m, 1H, CH-NH), 3.92-3.85 (m, 2H, CH2-C6H5), 3.29-3.01 (m, 2H, CH2O), 1.96-
1.95 (d, 3H, CH3-C-4, J = 1.2), 1.84 (s, 3H, CH3-C-2), 1.69-1.60 (m, 2H, 
P(CH(CH3)2)2) and 1.24-0.91 (m, 12H, P(CH(CH3)2)2); !C (75.39 MHz, C6D6, 298 K, 
TMS) 150.90 (C-7, imidazopyridazine), 143.33 (C-2, imidazopyridazine), 139.19 (C-4, 
imidazopyridazine), 138.89 (C-1’, C6H5), 137.29 (C-1’’, C6H5), 130.75, 129.89, 
128.58, 127.86 (Cm,o, C6H5), 129.61 (C-4a, imidazopyridazine), 126.90, 126.44 (Cp, 
C6H5), 117.84 (C-5, imidazopyridazine), 111.01 (C-3, imidazopyridazine), 72.76, 
72.41 (CH2O), 55.95, 55.84 (CH-NH), 38.28 (CH-CH2-C6H5), 28.68, 28.44, 28.40 
(P(CH(CH3)2)2), 21.08 (CH3-C-2), 19.41 (CH3-C-4) and 18.36, 18.29, 18.09, 18.01, 
17.34, 17.22 (P(CH(CH3)2)2); !P (121.37 MHz, C6D6, 298 K, TMS) 152.39. 
 
N-(1-((diethylphosphino)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-phenylimidazo[1,5-
b]pyridazin-7-amine 3f: 1.00 g (2.95 mmol) of 2-((2,4-dimethyl-5-phenylimidazo[1,5-
b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo and dissolved in 30 
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mL of dry diethyl ether/THF (1:1). The orange solution was cooled to -78 °C, then 
1.84 mL (2.95 mmol) of nBuLi (1.6 M in hexane) was added cautiously. Thereby, the 
solution changed its color to dark brown. The solution was stirred at -78 °C for 
another 30 minutes and warmed to room temperature. Then 0.36 mL (2.95 mmol) of 
chlorodiethylphosphine was added and the solution was stirred for 12 h at room 
temperature (color changes again to orange). The orange solution was evaporated to 
dryness and the orange residue was extracted with 15 mL of hexane (2x), the 
combined filtrates were evaporated to dryness yielding 3f (1.09 g, 86%) as an orange 
viscous product. Found:  C, 67.35; H, 8.7; N, 12.2; Calc. for C24H35N4OP*0.5 C4H10O 
(426.53 + 37.06): C, 67.4; H, 8.7; N, 12.1%. !H (299.83 MHz, C6D6, 298 K, TMS) 
7.74-7.71 (m, 2H, Ho, C6H5), 7.25-7.08 (m, 3H, Hm,p, C6H5), 5.26-5.25 (d, 1H, H-3, 
imidazopyridazine, J = 0.9), 5.04-5.01 (d, 1H, NH, J = 9.0), 4.55-4.50 (m, 1H, CH-
NH), 3.94-3.78 (m, 2H, CH2O), 1.96 (s, 3H, CH3-C-2), 1.85 (d, 3H, CH3-C-4, J = 0.9 
Hz), 1.66-1.42 (m, 3H, CH2CH(CH3)2), 1.33-1.21 (m, 4H, P(CH2CH3)2) and 1.06-0.85 
(m, 12H, P(CH2CH3)2, CH2CH(CH3)2); !C (75.39 MHz, C6D6, 298 K, TMS) 150.96 (C-
7, imidazopyridazine), 143.73 (C-2, imidazopyridazine), 138.96 (C-4, 
imidazopyridazine), 137.29 (C-1’, C6H5), 130.73 (Cp, C6H5), 129.56 (C-4a, 
imidazopyridazine), 127.91, 126.86 (Cm,o, C6H5), 117.80 (C-5, imidazopyridazine), 
110.91 (C-3, imidazopyridazine), 72.23 (CH2O), 52.34, 52.24 (CH-NH), 41.82 (CH-
CH2-CH), 25.20 (CH(CH3)2), 25.01, 24.98 (P(CH2CH3)2), 23.39, 22.50 (CH(CH3)2), 
21.06 (CH3-C-2), 19.42 (CH3-C-4) and 8.22, 8.15, 8.04, 7.96 (P(CH2CH3)2); !P 
(121.37 MHz, C6D6, 298 K, TMS) 138.69. 
 
N-(1-((di-t-butylphosphino)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3g: 0.50 g (1.48 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo 
and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 0.92 mL (1.48 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.28 
mL (1.48 mmol) of chlorodi-t-butylphosphine was added and the solution was stirred 
for 48 h at room temperature (color changes again to orange). The orange solution 
was evaporated to dryness and the orange residue was extracted with 15 mL of 
hexane (2x), the combined filtrates were evaporated to dryness yielding 3g (0.47 g, 
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66%) as an orange viscous product. Found:  C, 70.0; H, 9.3; N, 11.4. Calc. for 
C28H43N4OP (482.64): C, 69.7; H, 9.0; N, 11.6%. !H (299.83 MHz, CDCl3, 298 K, 
TMS) 7.48-7.45 (d, 2H, Ho, C6H5, J = 1.5), 7.32-7.29   (t, 2H, Hm, C6H5, J = 7.2), 7.23-
7.19 (m, 1H, Hp, C6H5), 5.81 (s, 1H, H-3, imidazopyridazine), 4.87-4.84 (d, 1H, NH, J 
= 9.9), 4.22-4.20 (m, 1H, CH-NH), 3.91-3.69 (m, 2H, CH2O), 2.23 (s, 3H, (CH3-C-
2/4), 2.10 (s, 3H, (CH3-C-4/2), 1.81-1.74 (m, 1H, CH(CH3)2), 1.69-1.47 (m, 2H, 
CH2CH(CH3)2), 1.17-1.13 (d, 3H, CH(CH3)2, J = 12.0), 1.04-1.01 (d, 3H, CH(CH3)2, J 
= 11.4) and 0.95-0.90 (m, 18H, P(C(CH3)3)2); !C (75.39 MHz, CDCl3, 298 K, TMS) 
151.39 (C-7, imidazopyridazine), 143.31 (C-2, imidazopyridazine), 139.48 (C-4, 
imidazopyridazine), 136.48 (C1’, C6H5), 130.52, 128.01 (Co,m, C6H5), 128.92 (C-4a, 
imidazopyridazine), 127.06 (Cp, C6H5), 117.63 (C-5, imidazopyridazine), 111.39 (C-3, 
imidazopyridazine), 75.36, 75.12 (CH2O), 52.38, 52.25  (CH-NH), 35.74, 35.67, 
35.43, 35.35 (P(C(CH3)3)2), 28.19, 27.97, 27.77, 27.69, 27.58, 27.50 (P(C(CH3)3)2), 
25.22 (CH(CH3)2), 23.47, 22.87 (CH(CH3)2) and 21.58, 19.73 (CH3-C-2/4 
imidazopyridazine); !P (121.37 MHz, CDCl3, 298 K, TMS) 157.29. 
 
N-(1-((dicyclohexylphosphino)oxy)-4-methylpentan-2-yl)-2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-amine 3h: 0.77 g (2.30 mmol) of 2-((2,4-dimethyl-5-
phenylimidazo[1,5-b]pyridazin-7-yl)amino)-4-methylpentan-1-ol was dried in vacuo 
and dissolved in 30 mL of dry diethyl ether/THF (1:1). The orange solution was 
cooled to -78 °C, then 1.44 mL (2.30 mmol) of nBuLi (1.6 M in hexane) was added 
cautiously. Thereby, the solution changed its color to dark brown. The solution was 
stirred at -78 °C for another 30 minutes and warmed to room temperature. Then 0.51 
mL (2.30 mmol) of chlorodicyclohexylphosphine was added and the solution was 
stirred for 24 h at room temperature (color changes again to orange). The orange 
solution was evaporated to dryness and the orange residue was extracted with 15 
mL of hexane (2x), the combined filtrates were evaporated to dryness yielding 3h 
(1.06 g, 86%) as an orange viscous product. Found:  C, 71.1; H, 9.1; N, 9.3. Calc. for 
C32H47N4OP*C4H8O (534.72 + 72.11): C, 71.25; H, 9.1; N, 9.2%. !H (299.83 MHz, 
C6D6, 298 K, TMS) 7.75-7.73 (m, 2H, Ho, C6H5), 7.26-6.07 (m, 3H, Hm,p, C6H5), 5.30 
(s, 1H, H-3, imidazopyridazine, J = 1.2), 5.09-5.06 (d, 1H, NH, J = 9.6), 4.58-4.53 (m, 
1H, CH-NH), 4.06-3.81 (m, 2H, CH2O), 2.01 (s, 3H, CH3-C-2), 1.88-1.87 (d, 3H, CH3-
C-4, J = 1.2), 1.72-1.50 (m, 14H, CH2CH(CH3)2, cyclohexyl), 1.29-1.12 (m, 11H, 
cyclohexyl), 0.99-0.97 (d, 3H, CH(CH3)2, J = 6.3) and 0.89-0.87 (d, 3H, CH(CH3)2, J = 
6.6); !C (75.39 MHz, C6D6, 298 K, TMS) 151.33 (C-7, imidazopyridazine), 144.18 (C-
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2, imidazopyridazine), 139.42 (C-4, imidazopyridazine), 137.74 (C-1’, C6H5), 131.15, 
128.31 (Cm,o, C6H5), 130.05 (C-4a, imidazopyridazine), 127.27 (Cp, C6H5), 118.18 (C-
5, imidazopyridazine), 111.24 (C-3, imidazopyridazine), 74.96 (CH2O), 52.95 (CH-
NH), 42.31 (CH-CH2-CH), 39.09, 38.84 (CH, cyclohexyl), 29.16, 28.91, 27.83, 27.78, 
27.73, 27.68, 27.59, 27.50, 27.27, 27.21 (CH2, cyclohexyl), 25.65 (CH(CH3)2), 23.75, 
22.98 (CH(CH3)2), 21.54 (CH3-C-2) and 19.84 (CH3-C-4); !P (121.37 MHz, C6D6, 298 
K, TMS) 147.73. 
5.6.3 Complex Synthesis 
[1,5-cyclooctadien-(N-(1-((diphenylphosphino)oxy)-4-methylpentan-2-yl)-2,4-
dimethyl-5-phenylimidazo[1,5-b]pyridazin-7-amido) rhodium (I)] 4a: To an orange 
solution of 0.50 g (0,96 mmol) N-(1-((diphenylphosphino)oxy)-4-methylpentan-2-yl)-
2,4-dimethyl-5-phenylimidazo[1,5-b]pyridazin-7-amine 3a in 20 mL of THF 0.23 g 
(0.47 mmol) 1,5-cyclooctadien-methoxy-rhodium (I) dimer was added, accompanied 
by a color change to blue/ dark green. The reaction solution was stirred at room 
temperature for 16 h. Then the THF volume was reduced in vacuo to 10 mL. At -30 
°C green crystals of 4a (0.26 g, 37%) were obtained. Found: C, 64.4; H, 6.7; N, 7.3. 
Calc. for C40H46N4OPRh*CH3OH (732.70 + 32.04): C, 64.4; H, 6.6; N, 7.3%. !H 
(299.83 MHz, CD2Cl2, 298 K, TMS) 7.62-7.56 (m, 2H, 3 x C6H5), 7.40-7.30 (m, 7H, 3 
x C6H5), 7.26-7.15 (m, 3H, 3 x C6H5), 7.03-6.95 (m, 3H, 3 x C6H5), 5.82 (br s, 1H, 
cod), 5.52 (s, 1H, H-3, imidazopyridazine), 4.92 (br s, 1H, cod), 4.77-4.61 (m, 2H, 
CH2O), 4.33-4.26 (m, 1H, CH-N), 2.81 (s, 3H, CH3-C-2), 2.65-2.53 (m, 2H, cod), 
2.40-2.22 (m, 4H, cod), 2.02-1.30 (m, 4H, cod), 1.84 (d, 3H, CH3-C-4), J = 0.9), 1.67-
1.58 (m, 2H, CH2CH(CH3)2), 1.42-1.39 (m, 1H, CH2CH(CH3)2), 1.23-1.22 (d, 3H, 
CH(CH3)2, J = 6.6) and 1.07-1.05 (d, 3H, CH(CH3)2, J = 6.6); !C (75.39 MHz, CD2Cl2, 
298 K, TMS) 155.98 (C-7, imidazopyridazine), 151.38 (C-2, imidazopyridazine), 
139.55 (C-4, imidazopyridazine), 138.22, 136.64, 135.93 (C1’, 3 x C6H5), 130.38 (C-
4a, imidazopyridazine), 130.22, 129.44, 129.29, 128.70, 128.65, 128.62, 128.57, 
128.48, 128.31, 128.26, 127.91, 127.47, 127.33, 126.37 (Co,m,p, 3 x C6H5), 115.02 (C-
5, imidazopyridazine), 110.00 (C-3, imidazopyridazine), 76.67 (CH2O), 57.80 (CH-N), 
55.12, 45.33 (CH, cod), 44.34 (CH-CH2-CH), 38.28, 33.59, 29.27, 28.56 (CH2, cod), 
28.27 (CH(CH3)2), 25.81, 24.39 (2 x CH3, CH(CH3)2) and 23.80, 19.23 (CH3-C-2/4); 
!P (121.37 MHz, CD2Cl2, 298K, TMS): 112.94 and 111.64; J = 158.4. 
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Details for X-ray crystal structure analysis of 4a, STOE-IDPS II equipped with an 
Oxford Cryostream low-temperature unit, graphite monochromatized MoK!-radiation, 
"=0.71069 Å, structure solution and refinements were accomplished with SHELXL-97 
(G. M. Sheldrick, SHELXL-97, Program for Crystal Structure Analysis Release 97-2, 
Institut für Anorganische Chemie der Universität Göttingen, Germany, 1998), WinGX 
(L. J. Farrugia, J. Appl. Crystallogr. 1999, 32, 837-838) and SIR97 (A. Altomare, M. 
C. Burla, M. Camalli, G. L. Cascarano, C. Giacovazzo, A. Guagliardi, A. G. G. 
Moliterni, G. Polidori and R. Spagna, J. Appl. Cryst. 1999, 32, 115-119), crystal size 
0.35 x 0.28 x 0.22 mm, symmetry space group R3, trigonal, a = 25.3240(8), b = 
25.3240(8), c = 13.5100(7) Å, ß= 90.00°, V = 7503.3(5) Å3, Z = 3, #cald. = 1.459 g/cm3, 
6257 reflections, 5601 independent reflections, R = 0.0251 [I > 2$(I)], wR2 (all data) 
= 0.0532, 426 parameters. CCDC-782981 contains the supplementary 
crystallographic data for this publication. These data can be obtained at 
www.ccdc.cam.ac.uk/data_request/cif free of charge (or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: + 44-
1223-336-033; E-mail: deposit@ccdc.cam.ac.uk). 
 
[1,5-cyclooctadien-(N-(1-((diisopropylphosphino)oxy)-4-methylpentan-2-yl)-2,4-
dimethyl-5-phenylimidazo[1,5-b]pyridazin-7-amido) rhodium (I)] 4b: To an orange 
solution of 0.35 g (0,76 mmol N-(1-((diisopropylphosphino)oxy)-4-methylpentan-2-yl)-
2,4-dimethyl-5-phenylimidazo[1,5-b]pyridazin-7-amine 3b in 20 mL of THF 0.19 g 
(0.38 mmol) 1,5-cyclooctadien-methoxy-rhodium (I) dimer was added, accompanied 
by a color change to blue/ dark green. The reaction solution was stirred at room 
temperature for 16 h. Then the THF volume was reduced to dryness in vacuo and 
(hot) hexane was added. The black-green solution was filtered off and reduced to 
dryness yielding 4b (0.18g, 36%). Found: C, 60.1; H, 7.7; N, 7.7. Calc. for 
C34H50N4OPRh*CH3OH (664.76 + 32.04): C, 60.3; H, 7.8; N, 8.0%. %H (250.13 MHz, 
[d8]THF, 298 K, TMS) 7.55-7.52 (d, 2H, Ho, C6H5, J = 7.0), 7.25-7.20 (t, 2H, Hm, C6H5, 
J = 7.8), 7.14-7.08 (m, 1H, Hp, C6H5), 5.60 (s, 1H, H-3), 5.49 (br s, 1H, CH, cod), 
4.33-4.15 (m, 3H, CH2O, CH-N), 3.78-3.70 (m, 2H, CH, cod), 3.36 (br s, 1H, CH, 
cod), 2.58 (s, 3H, CH3-C-2/4), 2.32-2.17 (m, 4H, CH2, cod), 2.08 (s, 3H, CH3-C-4/2), 
1.91-1.77 (m, 7H, CH2, cod, CH2CH(CH3)2), 1.31-1.13 (m, 8H, P(CH(CH3)2)2,  
PCH(CH3)2), 1.06-1.01 (t, 6H, CH(CH3)2, J = 6.3), 0.95-0.87 (dd, 3H, PCH(CH3)2, J = 
7.3) and 0.76-0.67 (dd, 3H, PCH(CH3)2, J = 7.3); %C (75.39 MHz, [d8]THF, 298 K, 
TMS)  155.51 (C-7, imidazopyridazine), 151.66 (C-2, imidazopyridazine), 140.17 (C-
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4, imidazopyridazine), 139.14 (C1’, C6H5), 132.16 (C-4a, imidazopyridazine), 130.76, 
128.02, 126.46 (Co,m,p, C6H5), 116.34 (C-5, imidazopyridazine), 110.11 (C-3, 
imidazopyridazine), 105.14 (CH, cod), 97.91 (CH, cod), 76.64 (CH2O), 66.43, 57.66 
(CH, cod), 56.65 (CH-N), 44.70 (CH-CH2-CH), 37.13, 33.41, 29.53, 28.83 (CH2, cod), 
30.48, 30.10, 29.40, 29.15, 29.09 (P(CH(CH3)2), 27.13 (CH(CH3)2), 24.84, 23.85 
(2xCH3, CH(CH3)2), 23.13, 20.07 (CH3-C-2/4) and 18.18, 18.15, 17.95, 17.04, 16.96, 
16.68, 16.62 (P(CH(CH3)2)2); !C (101.26 MHz, [d8]THF, 298 K, TMS) 141.15 and 
139.57; J = 160.9. 
 
4c-j: not isolated, precatalyst-solution prepared via alcohol elimination (refer to 5.5). 
5.6.4 Synthesis of Imines 
N-Aryl imines were synthesized according to Taguchi1 et al. – a solution of 0.1 mol 
amine, 0.1 mol ketone and 40 g of molecular sieves (4 Å) in 20 mL of diethyl ether 
was stirred for 24 hours. The molecular sieves were filtered off and washed with 
ether.  The combined filtrates were evaporated to dryness and the residue was 
purified via vacuum distillation (liquid residue) or recrystallization. 
 
N-(1-phenylethylidene)aniline 5a: yielded as a pale yellow solid (14.66 g, 75 %). M.p. 
37 °C. Found: C, 86.0; H, 6.9; N, 7.3. Calc. for C14H13N (195.26): C, 86.1; H, 6.7; N, 
7.2%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.97-7.94 (m, 2H, C6H5), 7.21-7.14 (m, 
5H, C6H5), 6.69-6.91 (t, 1H, C6H5, J = 7.2), 6.78-6.74 (m, 2H, C6H5) and 1.82 (s, 3H, 
CH3); !C (75.39 MHz, C6D6, 298 K, TMS) 164.34 (C=N), 152.45, 139.69 (Cq, C6H5), 
130.40, 129.14, 128.31, 127.54, 123.20, 119.58 (Co,m,p, C6H5) and 16.63 (CH3).    
 
N-(1-(p-tolyl)ethylidene)aniline 5b: yielded as a pale yellow solid (14.51 g, 70%). M.p. 
62 °C. Found: C, 85.7; H, 7.5; N, 6.8. Calc. for C15H15N (209.29): C, 86.1; H, 7.2; N, 
6.7%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.94-7.91 (d, 2H, aryl CH, J = 8.1), 7.21-
7.14 (m, 4H, aryl CH), 7.02-6.99 (d, 2H, aryl CH, J = 8.1), 6.96-6.91 (t, 1H, aryl CH, J 
= 7.2), 6.78-6.75 (d, 2H, aryl CH, J = 7.2), 2.09 (s, 3H, CH3) and 1.86 (s, 3H, CH3); !C 
(75.39 MHz, C6D6, 298 K, TMS) 164.00 (C=N), 152.41, 140.30, 137.00 (aryl Cq), 
128.96, 128.92, 127.44, 122.92, 119.53 (aryl CH) and 21.00, 16.47 (CH3). 
 
1 K. Taguchi, F. H. Westheimer, J. Org. Chem. 1971, 1570-1572. 
5.6 Supporting Information 
 55 
4-methoxy-N-(1-phenylethylidene)aniline 5c: yielded as a pale yellow solid (19.40 g, 
86%). M.p. 86 °C. Found: C, 79.5; H, 6.7; N, 6.1. Calc. for C15H15NO (225.29): C, 
80.0; H, 6.7; N; 6.2%. !H (399.80 MHz, [d6]DMSO, 298 K, TMS) 8.00-7.97 (m, 2H, 
C6H5), 7.48-7.45 (m, 3H, C6H5), 6.95-6.93 (d, 2H, C6H4OCH3,  J = 8.4), 6.76-6.74 (d, 
2H, C6H4OCH3, J = 8.4), 3.75 (s, 3H, OCH3) and 2.21 (s, 3H, CH3); !C (100.53 MHz, 
[d6]DMSO, 298 K, TMS) 165.59 (C=N), 156.15, 144.94, 139.87, 131.02, 128.94, 
127.70, 121.40, 114.86 (aryl Cq, aryl CH), 55.82 (OCH3) and 17.64 (CH3). 
 
3-methyl-N-(1-phenylethylidene)aniline 5d: yielded as a pale yellow solid (11.00 g, 
53%). M.p. 34 °C. Found: C, 85.8; H, 7.4; N, 6.8. Calc. for C15H15N (209.29): C, 86.1; 
H, 7.2; N, 6.7%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.99-7.96 (m, 2H, aryl CH); 
7.18-7.12 (m, 4H, aryl CH); 6.80-6.78 (d, 1H, aryl CH, J = 7.5), 6.63-6.60 (d, 2H, aryl 
CH, J = 8.7), 2.14 (s, 3H, CH3) and 1.86 (s, 3H, CH3); !C (75.39 MHz, C6D6, 298 K, 
TMS) 164.10 (C=N), 152.54, 139.80, 139.67 (aryl Cq), 130.34, 129.04, 128.31, 
127.52, 123.98, 120.22, 116.64 (aryl CH), 21.37 (CH3) and 16.68 (CH3). 
 
3,5-dimethyl-N-(1-phenylethylidene)aniline 5e: yielded as an orange liquid (14.40 g, 
65%). Found: C, 85.6, H, 7.5; N, 6.6. Calc. for C16H17N (223.31): C, 86.05; H, 7.7; N, 
6.3%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 7.98-7.95 (m, 2H, C6H5), 7.48-7.46 
(m, 3H, C6H5), 6.69 (s, 1H, Hp, C6H3(CH3)2), 6.38 (s, 2H, Ho, C6H3(CH3)2), 2.26 (s, 
6H, C6H3(CH3)2) and 2.17 (s, 3H, CH3); !C (75.39 MHz, [d6]DMSO, 298 K, TMS) 
164.40 (C=N), 151.37, 138.98, 137.95, 130.34, 128.23, 127.00, 124.49, 116.74 (aryl 
Cq, aryl CH), 20.92 (2x CH3, C6H3(CH3)2) and 16.97 (CH3). 
 
3-methyl-N-(1-(p-tolyl)ethylidene)aniline 5f: yielded as an orange liquid (18.20 g, 
82%). Found: C, 85.9; H, 8.2; N, 6.6. Calc. for C16H17N (223.31): C, 86.05; H, 7.7; N, 
6.3%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 7.88-7.86 (d, 2H, aryl CH, J = 8.1), 
7.29-7.20 (m, 3H, aryl CH), 6.89-6.86 (dd, 1H, aryl CH, J = 7.8, 0.9), 6.58-6.54 (m, 
2H, aryl CH), 2.36 (s, 3H, m-CH3), 2.30 (s, 3H, p-CH3) and 2.16 (s, 3H, CH3); !C 
(75.39 MHz, [d6]DMSO, 298 K, TMS) 164.37 (C=N), 151.44, 140.20, 138.17, 136.28, 
128.89, 128.78, 127.03, 123.60, 119.75, 116.29 (aryl Cq, aryl CH), 21.02 (m-CH3), 
20.90 (p-CH3) and 16.94 (CH3). 
 
4-methoxy-N-(1-(p-tolyl)ethylidene)aniline 5g: yielded as a pale yellow solid (10.68 g; 
45%). M.p. 83 °C. Found: C, 80.2; H, 7.4; N, 5.9. Calc. for C16H17NO (239.31): C, 
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80.3; H, 7.2;  N, 5.85%. !H (299.83 MHz, CDCl3, 298 K, TMS) 7.91-7.89 (d, 2H, aryl 
CH, J = 8.1), 7.29-7.26 (d, 2H, aryl CH, J = 8.1), 6.95-6.92 (d, 2H, aryl CH,  J = 9.0), 
6.80-6.77 (d, 2H, aryl CH, J = 9.0), 3.84 (s, 3H, OCH3), 2.44 (s, 3H, CH3) and 2.26 (s, 
3H, CH3); !C (75.39 MHz, CDCl3, 298 K, TMS): 165.79 (C=N), 156.11, 145.22, 
140.79, 137.33, 129.30, 127.36, 121.08, 114.47 (aryl Cq, aryl CH), 55.73 (OCH3), 
21.64 (p-CH3) and 17.49 (CH3). 
 
4-butyl-N-(1-(p-tolyl)ethylidene)aniline 5h: yielded as yellow liquid (8.01 g, 60%). 
Found: C, 85.7; H, 8.9; N, 5.25. Calc. for C19H23N (265.39): C, 86.0; H, 8.7; N, 5.3%. 
!H (299.83 MHz, C6D6, 298 K, TMS) 8.02-7.99 (d, 2H, aryl CH, J = 8.1), 7.36-7.33 (d, 
2H, aryl CH, J = 8.4), 7.29-7.26 (d, 2H, aryl CH, J = 8.1), 6.86-6.83 (d, 2H, aryl CH, J 
= 7.8), 2.76-2.71 (t, 2H, CH2Pr, J = 7.5), 2.51 (s, 3H, CH3), 2.32 (s, 3H, p-CH3), 1.81-
1.70 (q, 2H, CH2CH2Et, J = 6.9), 1.55-1.48 (m, 2H, (CH2)2CH2CH3) and 1.11-1.06 (t, 
3H, -(CH2)3CH3, J = 7.5); !C (75.39 MHz, C6D6, 298 K, TMS) 163.36 (C=N), 147.87, 
138.87, 135.91, 135.44 (aryl Cq), 127.45, 127.26, 125.61, 117.91 (aryl CH), 33.58, 
32.28, 20.85 (CH2) 19.79 (CH3), 15.58 (CH3)  and 12.51 (CH3). 
 
N-(1-phenylpropylidene)aniline 5i: yielded as pale yellow solid (12.76 g, 61%). M.p. 
49 °C. Found: C, 85.6; H, 7.4; N, 6.9. Calc. for C18H15N (209.29): C, 86.1; H, 7.2; N, 
6.8%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.96-7.91 (m, 2H, aryl CH), 7.21-7.14 (m, 
5H, aryl CH), 6.95-6.90 (t, 1H, aryl CH, J = 7.2), 6.79-6.77 (d, 2H, aryl CH, J = 7.2), 
2.43-2.35 (q, 2H, CH2, J = 7.8) and 0.84-0.79 (t, 3H, CH3, J = 7.8); !C (75.39 MHz, 
C6D6, 298 K, TMS) 169.45 (C=N), 152.45, 138.20 (Cq, C6H5), 130.14, 129.00, 
128.30, 127.43, 122.80, 119.03 (Co,m,p, C6H5), 22.90 (CH2) and 12.67 (CH3). 
 
N-(1-phenylhexylidene)aniline 5j: yielded as an orange liquid (9.40 g, 47%). Found: 
C, 85.5; H, 8.9; N, 5.8. Calc. for C18H21N (251.37): C, 86.0; H, 8.4; N, 5.6%. !H 
(299.83 MHz, [d6]DMSO, 298 K, TMS) 7.94-7.91 (m, 2H, C6H5), 7.50-7.46 (m, 3H, 
C6H5), 7.38-7.32 (t, 2H, C6H5, J = 7.5), 7.09-7.04 (t, 1H, C6H5, J = 7.5), 6.76-6.73 (d, 
2H, C6H5, J = 7.2), 2.64-2.59 (t, 2H, CH2, J = 7.8), 1.41-1.34 (m, 2H, CH2), 1.12-1.05 
(m, 4H, 2x CH2) and 0.74-0.69 (t, 3H, CH3, J = 6.9); !C (75.39 MHz, [d6]DMSO, 298 
K, TMS) 169.02 (C=N), 151.27, 137.81, 130.36, 128.92, 128.42, 127.44, 122.81, 
118.79 (aryl Cq, aryl CH), 30.98 (CH2), 29.27 (CH2), 27.05 (CH2), 21.44 (CH2) and 
13.57 (CH3). 
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N-(2,2-dimethyl-1-phenylpropylidene)aniline 5k: 0.05 mol of the ketone and 0.05 mol 
of the amine were refluxed in 15mL of benzene, 15.0 g of molecular sieves and 
catalytic amounts of p-toluenesulfonic acid. The yellow solution was filtered off the 
molecular sieves and distilled (high vacuum) yielding 5n (1.98 g, 17%) as a light 
yellow liquid. Found: C, 85.7; H, 8.3; N, 5.9. Calc. for C17H19N (237.34): C, 86.0; H, 
8.1; N, 5.9%. !H (250.13 MHz, CDCl3, 298 K, TMS) 7.16-7.10 (m, 3H, C6H5), 7.07-
7.00 (m, 2H, C6H5), 6.94-6.90 (m, 2H, C6H5), 6.80-6.74 (m, 1H, C6H5), 6.56-6.52 (m, 
2H, C6H5) and 1.27 (s, 9H, C(CH3)3); !C (75.39 MHz, [d6]DMSO, 298 K, TMS) 179.83 
(C=N), 152.07, 137.27, 135.38, 129.48, 128.85 128.75, 128.34, 128.30, 127.99, 
120.39, 114.66, (aryl Cq, aryl CH), 40.38 (C(CH3)3) and 28.44 (C(CH3)3).  
 
N-(1-(4-bromophenyl)ethylidene)aniline 5l: yielded as pale yellow solid (24.80 g, 
90%). M.p. 87 °C. Found: C, 61.2; H, 4.5; N, 5.0. Calc. for C14H12BrN (274.16): C, 
61.3; H, 4.4; N, 5.1%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.57-7.54 (d, 2H, aryl CH, 
J = 8.7), 7.27-7.24 (d, 2H, aryl CH, J = 8.7), 7.18-7.12 (m, 2H, aryl CH), 6.94-6.89 (t, 
1H, aryl CH, J = 7.5), 6.70-6.67 (d, 2H, aryl CH, J = 8.1) and 1.66 (s, 3H, CH3); !C 
(75.39 MHz, C6D6, 298 K, TMS) 163.16 (C=N); 151.81, 138.20, 124.96 (aryl Cq); 
131.29, 128.96, 128.91, 124.96, 123.24, 119.30 (aryl CH) and 16.21 (CH3). 
 
N-(1-(3,4-dimethoxyphenyl)ethylidene)aniline 5m: yielded as pale yellow solid (10.55 
g, 41%). M.p. 115 °C. Found: C, 74.8; H, 7.2; N, 5.1. Calc. for C16H17NO2 (255.31): 
C, 75.3; H, 6.7; N, 5.5%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.75-7.74 (d, 1H, H-2, 
C6H3(OCH3)2, J = 1.8), 7.48-7.44 (dd, 1H, H-5, C6H3(OCH3)2, J = 8.4, 2.1), 7.36-7.34 
(t, 2H, Hm, C6H5, J = 7.5), 7.12-7.07 (t, 1H, Hp, C6H5, J = 7.5), 6.92-6.90 (d, 1H, 
C6H3(OCH3)2, J = 8.4), 6.83-6.80 (d, 2H, Ho, C6H5, J = 8.7), 3.98-3.95 (m, 6H, 2x 
OCH3) and 2.22 (s, 3H, CH3); !C (100.53 MHz, [d6]DMSO, 298 K, TMS) 164.70 
(C=N), 152.22, 151.75, 149.11, 132.18, 129.60, 123.51, 121.61, 120.10, 111.43, 
110.23 (aryl Cq, aryl CH), 56.23 (OCH3), 56.07 (OCH3) and 17.52 (CH3). 
 
N-(1-(naphthalen-2-yl)ethylidene)aniline 5n: yielded as a pale yellow solid (10.07 g, 
60%). M.p. 140 °C. Found: C, 88.0; H, 6.1; N, 5.8. Calc. for C18H15N (245.32): C, 
88.1; H, 6.2; N, 5.7%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 8.51 (s, 1H, 2-
naphtyl), 8.23-8.20 (dd, 1H, 2-naphtyl, J = 1.8), 8.09-8.06 (m, 1H, 2-naphtyl), 8.00-
7.97 (m, 2H, 2-naphtyl), 7.61-7.58 (m, 2H, 2-naphtyl), 7.42-7.36 (t, 2H, Hm, C6H5), 
7.13-7.08 (t, 1H, Hp, C6H5), 6.86-6.83 (d, 2H, Ho, C6H5) and 2.33 (s, 3H, CH3); !C 
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(75.39 MHz, [d6]DMSO, 298 K, TMS): 164.83 (C=N), 151.36, 136.21, 133.90, 132.54 
(aryl Cq), 128.97, 127.90, 127.68, 127.52, 127.36, 126.51, 123.94, 123.12, 119.30 
(aryl CH) and 17.09 (CH3).  
5.6.5 Optimization of Reaction Conditions 
Reaction conditions were optimized for the asymmetric hydrogenation of imine 5a 
with 4b. Conversion and enantioselectivity were determined via GC and HPLC. 
Based on these results (Tables 4-7) it was chosen to use 20 °C (rt), a large excess of 
KOtBu and 20 bar of H2 pressure as standard reaction conditions.  
 
Table 4: Base Screening, 48h, 0.1 mol% 4b, rt, 20 bar. 
No. Base Conv. [%] ee [%] 
1 - 37 - 
2 NaNH2 25 66 
3 NaOtBu 44 80 
4 LiOtBu 34 43 
5 KOtBu >99 90 
6 KOH >99 90 
7 KOSiMe3 38 31 
8 KN(SiMe3)2 96 86 
9 K2CO3 27 86 
10 NEtiPr2 - - 
 
Table 5: Screening – Amount of Base, 24h, 0.1 mol% 4b, rt, 20 bar. 
No. Base : Catalyst Conv. [%] ee [%] 
1 1 : 100 - - 
2 1 : 10 - - 
3 1 : 1 - - 
4 4 : 1 - - 
5 6 : 1 51 89 
6 8 : 1 >99 90 
7 10 : 1 >99 90 
8 100 : 1 >99 89 
9 1000 : 1 >99 90 
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Table 6: Pressure Screening, 24h, 0.1 mol% 4b, rt, KOtBu. 
No. p [bar] Conv. [%] ee [%] 
1 60 >99 88 
2 40 98 90 
3 30 >99 90 
4 20 >99 90 
5 10 62 89 
6 5 46 87 
Table 7: Temperature Screening, 48h, 0.1 mol% 4b, KOtBu, 20 bar. 
No. T [°C] Conv. [%] ee [%] 
1 40 >99 84 
2 20 >99 90 
3 10 >99 92 
4 0 92 93 
5 -20 64 95 
5.6.6 Hydrogenation of Miscellaneous Imines 
Table 8: Hydrogenation of miscellaneous N-aryl imines with 4b. 
 
 
 
No. Imine Yield[a] [%] ee[b] [%] Lit. ee [%] 
1* 5l 
 
35.2 97 91[3f] 
2* 5m 
 
74 89 97[4e] 
3# 5n 
 
57 91 95[4e] 
0.1 mol% (*0.2 mol%) 4b, KOtBu, 48 h (#24 h), rt, 20 bar H2; [a] determined via GC; [b] determined via HPLC. 
 
 
N
Br
N
OCH3
OCH3
N
R1
R2
N
R3 R1
R2
NH
R30.1-0.2 mol% 4b
KOtBu, 20 bar H2
5
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5.6.7 Characterization (HPLC, GC) 
Conversion:  
The conversion (*and ee) was determined with dodecane as internal standard via 
gas chromatography. 
 
5a-e,f,i-l: Instrument setup: Thermo Focus GC, column: Chirasil-DEX (Varian), Split 
flow 60.8 mL/min, Carrier He 3.4 mL/min, Inlet 250 °C; GC program: 105 °C hold 1’, 
heat 30 °C/min till 150 °C (hold 3’), heat 6 °C/min until 215 °C (hold 12’). 
 
Retention Times:  
5a:  Dodecane: 7.2 min  Amine: 16.8 min  Imine: 7.3 min 
5b:  Dodecane: 7.3 min  Amine: 18.8 min  Imine: 9.7 min 
5c:  Dodecane: 7.2 min   Amine: 22.6 min  Imine: 23.4 min 
5d:  Dodecane: 7.2 min   Amine: 18.2 min  Imine: 18.7 min 
5e:  Dodecane: 7.4 min   Amine: 24.8 min  Imine: 21.0 min 
5f:  Dodecane: 7.3 min  Amine: 20.3 min  Imine: 19.5 min 
5i: Dodecane: 7.2 min   Amine: 17.9 min  Imine: 16.8 min 
5j:  Dodecane: 7.3 min  Amine: 22.5 min  Imine: 24.8 min 
5k*:  Dodecane: 7.4 min  Amine: 18.9, 19.1 min Imine: 15.7 min  
5l:  Dodecane: 7.3 min  Amine: 17.3 min  Imine: 26.1 min 
 
5g: Instrument setup: Thermo Focus GC, column: Chirasil-DEX (Varian), Split flow 
60.8 mL/min, Carrier He 3.4 mL/min, Inlet 250 °C; GC program: 105 °C hold 1’, heat 
30 °C/min till 150 °C (hold 3’), heat 25 °C/min till 200 °C (hold 2’), heat 5 °C/min until 
215 °C (hold 18’). 
 
Retention Times: 
5g: Dodecane: 6.9 min  Amine: 22.0 min  Imine: 24.4   
  
5h,m,n:Instrument setup: Agilent 6890N Network GC, column: Lipodex-E (Machery-
Nagel), Split flow 61.0 mL/min, Carrier He 1.0 mL/min, Inlet 250 °C; GC program: 110 
°C hold 5’, heat 20 °C/min till 215 °C (hold 30’). 
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Retention Times:  
5h: Dodecane: 3.8 min   Amine: 18.0 min   Imine: 19.4 min  
5m: Dodecane: 4.3 min   Amine: 22.1 min   Imine: 19.5 min 
5n:  Dodecane: 3.8 min   Amine: 24.5 min   Imine: 25.7 min 
 
 
Enantiomeric excess:  
The enantiomeric excess was determined via HPLC (Agilent 1200) with a Chiralpak 
IB (Daicel) column.  
 
5a: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 12.6 (S), 14.3 (R) min; (Imine: 15.7 min) 
 
 
5b: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 10.8, 11.8 min; (Imine: 16.4 min) 
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5c: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 20.8, 21.4; Imine: 28.2 
 
 
 
 
 
 
 
 
 
 
5d: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 11.0 (-), 13.0 (+) 
 
 
5e: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 9.2, 10.1 min; Imine: 9.6 min 
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5f: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 10.1, 11.3 min; Imine: 13.3 min 
 
 
 
 
 
 
 
 
 
 
5g: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.5:0.5 Hexane: 2-Propanol 
Retention Times: Amine: 12.7, 13.6 min 
 
 
 
 
 
 
 
 
 
 
 
5h: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 7.4, 7.9 min 
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5i: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 10.0, 11.0 min 
 
 
 
 
 
 
 
 
 
5j: 30 °C, 254 nm, Flow 1 mL/min, 99:1 Hexane: 2-Propanol 
Retention Times: Amine: 5.5, 6.1 min; Imine: 22.3 min 
 
 
 
 
 
 
 
 
 
 
5l: 30 °C, 240 nm, Flow 1 mL/min, 99.7:0.3 Hexane: 2-Propanol 
Retention Times: Amine: 12.5, 15.4 Amin; Imine: 9.7 min 
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5m: 30 °C, 240 nm, Flow 0.4 mL/min, 97:3 Hexane: 2-Propanol 
Retention Times: Amine: 35.3, 36.2 min; Imine: 30.4 min 
 
 
 
 
 
 
 
 
 
 
5n: 30 °C, 254 & 240 nm, Flow 1 mL/min, 99:1 Hexane: 2-Propanol 
Retention Times: Amine: 11.0, 11.7; Imine: 12.7 
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Abstract: A novel reaction, the potassium hydride mediated synthesis of fulvenes, is 
described. The synthesis utilizes N-aryl imines as inexpensive starting material 
affording novel substituted aminofulvenes. It is proposed that the presence of the 
metalated enamine as well as the imine (ratio 2:1) leads to the formation of an initial 
trimerization product, which cyclizes, giving rise to the aminofulvene. 
6.1 Introduction  
Pentafulvenes, first described by Thiele at the beginning of this century,[1] attracted 
much interest due to their color,[2] reactivity (especially cycloadditions[3]), dipole 
moment[4] and questions regarding their aromatic or anti-aromatic[5] character. 
Furthermore they represent a class of very interesting organic ligands. Various 
organometallic compounds, being applied for instance as polymerization catalysts[6] 
or anticancer agents,[7] have been synthesized via fulvene routes.[8] Fulvenes can be 
obtained by condensation reaction[9] of aldehydes or ketones with cyclopentadienyl. 
Additionally, a few other methods can be utilized.[10] Herein we report a novel 
potassium hydride mediated approach towards 1,3,6-substituted 6-aminofulvenes. 
The imine trimerization reaction is based on tautomerization into metalated enamines 
and proceeds via C-H activation and multiple C-C bond formation steps. 
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6.2 Results and Discussion 
Within the base optimization experiments for the enantioselective hydrogenation[11] of 
1a (Fig. 1), the formation of a by-product was observed if KH was utilized as a base. 
A dark red material crystallized in one of the catalysis samples. It was identified as 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-phenyl-amine 2a (Fig. 1).  
Figure 1: Retrosynthetic approach towards novel fulvenes. 
Upon this discovery, we were interested in understanding and using the side 
reaction. A precise reaction stoichiometry (imine : KH ratio) is crucial to yield fulvenes 
as main product. Addition of a large excess of potassium hydride (3 eq.) led to amine 
formation, whilst using one equivalent mainly yielded the imine starting material (after 
workup). Upon utilization of 0.7 equivalents of potassium hydride, complete 
conversion of the imine to the corresponding 6-aminofulvene as main product was 
observed (Fig. 2). The addition of several metal bases was investigated. Only the 
utilization of potassium hydride gave rise to fulvene 2a with complete conversion of 
the starting material.  
Figure 2: Synthesis of fulvenes from N-aryl imines. 
Upon the addition of potassium hydride to imines 1a-i the color of the reaction 
solution changed quickly to green and then dark red, accompanied by hydrogen 
evolution. The corresponding fulvenes 2a-i were obtained as dark red materials in 
moderate yields (Fig. 3). 
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Figure 3: 6-aminofulvenes 2a-i. 
A time-conversion plot was realized to gain additional insight into mechanistic details 
of this novel reaction (Fig. 4). The isolated yield of the fulvene is consistent with the 
GC-yield, which was obtained in the kinetic experiment. Additionally, the formation of 
an intermediate (3a) and a by-product (4a) could be observed as well as the 
formation of aniline. The key intermediate (1,3-diphenyl-but-3-enylidene)-phenyl-
amine (3a) was independently synthesized. Reduction of 3a gives rise (after aqueous 
work up) to the by-product (1,3-diphenyl-butylidene)-phenyl-amine (4a), which could 
be isolated from the reaction mixture and was characterized via NMR spectroscopy 
and EA.  
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Figure 4: Time-conversion plot; determined via GC with dodecane as internal 
standard. 
The potassium cyclopentadienylimine complex 5a was crystallized from the reaction 
mixture and was analyzed via X-Ray crystal structure analysis to determine the 
molecular structure (Fig. 5).  
Figure 5: Molecular structure of 5a; selected bond lengths [Å] and angles [°]: C1-C2, 
1.404(5); C1-C24, 1.416(6); C2-C3, 1.409(6); C3-C4, 1.386(6); C4-C24, 1.425(6); C17-
K1, 3.208(4); C22-K1, 3.229; C23-N1, 1.304(5); C23-C24, 1.458(6); N1-K1, 2.814(4); 
N1-C22-K1, 60.4(2); N1-C23-C24, 120.1(4); N1-C23-C25, 122.5(4); C23-N1-C22, 
121.4(4). 
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In the dimeric complex 5a, the potassium is coordinated by the N-atom and further 
stabilized by !-coordination of the electron rich phenyl substituents of 5a and the 
cyclopentadienyl moiety of a second ligand molecule. The bond lengths of 5a differ 
significantly from the bond lengths of the isolated fulvene 2a. Whereas in 2a the three 
double bonds (1.36-1.38 Å) are notably shorter than the sigma-bonds (1.45-1.47 Å), 
in 5a only the C3-C4 bond length (1.39 Å) is in the supposed range. The other C-C 
bond lengths vary between 1.40 and 1.46 Å. The C-N bond length of only 1.304 Å 
indicates a C-N double bond. These data provide a consistent picture of the 
coordinated ligand as a cyclopentadienylimine rather than an amidofulvene. The 
standard deviation of the cyclopentadienyl plane is 0.005 Å. The nitrogen atom is out 
of this plane (distance 0.41 Å), because it coordinates the potassium atom.  
Figure 6: Proposed reaction mechanism. 
Since Knorr et al.[12] reported the formation of metastable secondary enamines via 
lithiation of imines with lithium diisopropylamide, we assumed that enamine-formation 
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upon potassium hydride addition is a crucial reaction step in fulvene formation. The 
two olefinic hydrogen-atoms of the enamine 6a were detected as doublets (J = 1.4 
Hz) at 4.29 and 4.12 ppm (solvent C6D6:THF-d8 10:1).  
The presence of the imine as well as the enamine is necessary for the reaction to 
take place, which is supported by the results of the KH : imine ratio screening. As 
indicated in Figure 6, the enamine species 6a attacks the C-atom of the C=N bond[13] 
of 1a to yield (1,3-diphenyl-but-3-enylidene)-phenyl-amine 3a, thereby potassium 
anilide is eliminated. A second attack of 6a at the imino-group of 3a occurs and 
subsequently the trimerization product 7a cyclizes to 5a. The proposed mechanism is 
summarized in Figure 6. 
The reaction of N-alkyl imines, N-phenyl-(1-phenyl-propylidene)-amines, or N-phenyl-
(1-alkyl-ethylidene)-amines with potassium hydride did not yield the corresponding 
fulvenes. NMR-experiments upon KH addition suggested that the tautomerization to 
aldimines or isomerization of the double bond into the alkyl-chain prevents the initial 
attack. 
6.3 Conclusions 
In conclusion, a novel reation was discovered. A series of novel 1,3,6-substituted 6-
aminofulvenes was synthesized by a facile approach, which utilizes inexpensive and 
readily available imines as starting material. Furthermore, the mechanism of the 
reaction was investigated. We propose that the potassium-mediated trimerization 
reaction of N-aryl imines proceeds via an observed dimerization and transient 
trimerization product, which subsequently cyclizes, thereby giving rise to novel 
fulvenes.  
Supporting Information available 
Supporting information including crystallographic data, characterization data, and 
detailed experimental procedures is available (Refer to 6.6). 
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6.4 Experimental Section  
General procedure for the synthesis of fulvenes: In a pressure tube 20.0 mmol of 
the imine 1 were dissolved in about 10.0 mL of THF. Then 0.57 g (14.0 mmol) of 
potassium hydride were added, immediately the color changed from orange to green 
and a second color change to dark red, accompanied by hydrogen evolution, took 
place. The dark brown solution was heated under slight reflux for three to four days. 
Then it was cooled to room temperature and water (about 5 mL) was added. The 
solution was extracted with diethyl ether (10 mL), the organic phase was dried over 
Na2SO4 and evaporated to dryness by rotary evaporation. The dark red product was 
purified via column chromatography (n-hexane/ ethyl acetate) or recrystallized. 
Synthesis of [(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-phenyl-amine 
2a: yielded as red crystalline product (1.18 g, 45%). M.p. 160-170 °C. Found: C, 
90.3; H, 5.7; N, 3.6. Calc. for C30H23N (397.51): C, 90.6; H, 5.8; N, 3.5%. !H (299.83 
MHz, C6D6, 298 K, TMS) 7.34-7.27 (m, 5H), 7.15-7.14 (d, 1H, J = 1.5), 7.13-7.12 (d, 
1H, J = 2.1), 6.92-6.67 (m, 9H), 6.43-6.39 (m, 4H), 6.29-6.24 (t, 1H, J = 7.5) and 
5.90-5.87 (d, 2H, J = 7.5); !C (63,89 MHz, CDCl3, 298 K, TMS) 154.51, 141.83, 
140.68, 139.21, 138.75, 136.85, 136.46, 124.25 (Cq fulvene, aryl Cq), 133.08, 130.85, 
130.80, 130.73, 130.39, 130.21, 127.17, 122.86 (Co,m, aryl CH), 132.06, 129.02, 
128.59, 127.87, 125.27 and 121.95 (Cp, aryl CH, CH fulvene). 
6.5 References 
[1]  J. Thiele, H. Balhorn, Liebigs Ann. Chem. 1906, 348, 1-15. 
[2] a) A. L. Sklar, Journal of Chemical Physics 1937, 5, 669-681;  b) E. 
Bergmann, Ber. Dtsch. Chem. Ges. 1930, 63, 6, 1617-1631; c) N. C. Courtot, 
Ann. Chim. Appl. 1915, 4, 168-224. 
[3]  a) K. J. Lee, J.-K. Choi, E. K. Yum, S. Y. Cho, Tetrahedron Lett. 2009, 50, 
6698-6700; b) J. Barluenga, S. Martinez, A. L. Suarez-Sobrino, M. Tomas, J. 
Am. Chem. Soc. 2002, 124, 5948-5949; c) J. Barluenga, S. Martinez, A. L. 
Suarez-Sobrino, M. Tomas, J. Am. Chem. Soc. 2001, 123, 11113-11114; d) Y. 
Himeda, H. Yamataka, I. Ueda, M. Hatanaka, J. Org. Chem. 1997, 62, 6529-
6538; e) J. W. Coe, M. G. Vetelino, D. S. Kemp, Tetrahedron Lett. 1994, 35, 
6627-6630; f) J. H. Rigby, in: B. M. Trost, I. Fleming (Eds.) Comprehensive 
Organic Synthesis, Vol. 5, Pergamon Press, Oxford, 1991, pp. 626; g) Y. 
6. The Potassium Hydride Mediated Trimerization of Imines 
 74 
Wang, D. Mukherjee, D. Birney, K. N. Houk, J. Org. Chem. 1990, 55, 4504- 
4506; h) I. Fleming,  Frontier Orbitals and Organic Chemical Reactions, John 
Wiley & Sons, New York, 1985, pp. 178-181; i) K. N. Houk, L. J. Luskus, J. 
Org. Chem. 1973, 38, 3836-3843. 
[4] a) E. S. Replogle, G. W. Trucks, S. W. Staley, J. Phys. Chem. 1991, 95, 6908-
6912; b) R. S. Mulliken in: S. P. Parker (Ed.), McGraw-Hill Encyclopedia of 
Chemistry, McGraw-Hill, New York, 1982, p. 215; c) P. Yates, in: H. Hart, G. J. 
Karabatsos (Ed.), Advances in Alicyclic Chemistry, Vol. 2, Academic Press, 
New York, 1968, p. 59; d) G. W. Wheland, D. E. Mann, J. Chem. Phys. 1949, 
17, 264-268. 
[5]   a) M. Alonso, B. Herradon, J. Comput. Chem. 2009, DOI 10.1002/jcc; b) H. 
Möllerstedt, M. C. Piqueras, R. Crespo, H. Ottosson, J. Am. Chem. Soc. 2004, 
126, 13938-13939; c) V. I. Minkin, M. N. Glukhovtsev, B. Ya. Simkin, 
Aromaticity and Antiaromaticity: Electronic and Structural Aspects, Wiley, New 
York, 1994.  
[6] a) X. Yang, Y. Zhang, J. Huang, Appl. Organomet. Chem. 2006, 20, 130-137; 
b) J. Paradies, G. Kehr, R. Fröhlich, G. Erker, Proc. Natl. Acad. Sci. 2006, 103, 
15333-15337; c) G. Erker, Chem. Commun. 2003, 1469-1476; d) H. G. Alt, A. 
Köppl, Chem. Rev. 2000, 10, 1205-1221; e) A. Bertuleit, M. Könemann, L. 
Duda, G. Erker, R. Fröhlich, Topics in Catalysis 1999, 7, 37-44; f) W. 
Kaminsky, Dalton Trans. 1998, 1413-1418; g) M. Bochmann, Dalton Trans. 
1996, 255-270; h) H. H. Brintzinger, D. Fischer, R. Mülhaupt, B. Rieger, R. M. 
Waymouth, Angew. Chem. Int. Ed. 1995, 34, 1143-1170; i) T. J. Marks, Acc. 
Chem. Res. 1992, 25, 57-65.  
[7] a) K. Strohfeldt, M. Tacke, Chem. Soc. Rev. 2008, 37, 1174-1187; b) C. 
Pampillón, N. J. Sweeney, K. Strohfeldt, M. Tacke, J. Organomet. Chem. 
2007, 692, 2153-2159; c) F.-J. K. Rehmann, L. P. Cuffe, O. Mendoza, D. K. 
Rai, N. Sweeney, K. Strohfeldt, W. M. Gallagher, M. Tacke, Appl. Organomet. 
Chem. 2005, 19, 293-300; c) M. Tacke, L. T. Allen, L. Cuffe, W. M. Gallagher, 
Y. Lou, O. Mendoza, H. Müller-Bunz, F.-J. Rehmann, N. Sweeney, J. 
Organomet. Chem. 2004, 689, 2242-2249; d) P. Köpf-Maier, H. Köpf, Chem. 
Rev. 1987, 87, 1137-1152. 
[8]  a) G. Erker, G. Kehr, R. Fröhlich, Organometallics 2008, 27, 3-14; b) G. Erker, 
Coord. Chem. Rev. 2006, 250, 1056-1070; c) G. Erker, Coord. Chem. Rev. 
6.5 References 
 75 
2006, 250, 36-46; d) M. Diekmann, G. Bocksteigel, A. Lützen, M. Friedemann, 
W. Saak, D. Haase, R. Beckhaus, Organometallics 2006, 25, 339-348; e) R. 
Koch, E. Bölter, J. Stroot, R. Beckhaus, J. Organomet. Chem. 2006, 691, 
4539-4544; f) Y. C. Won, H. Y. Kwon, B. Y. Lee, Y.-W. Park, J. Organomet. 
Chem. 2003, 667, 133-139; g) K. Kunz, G. Erker, S. Döring, S. Bredeau, G. 
Kehr, R. Fröhlich, Organometallics 2002, 21, 1021-1041; h) R. Beckhaus, A. 
Lützen, D. Haase, W. Saak, J. Stroot, S. Becke, J. Heinrichs, Angew. Chem. 
Int. Ed. 2001, 40, 2056-2058; i) T. Koch, S. Blaurock, F. B. Somoza, A. Voigt, 
R. Kirmse, E. Hey-Hawkins, Organometallics 2000, 19, 2556-2563; j) H. G. Alt, 
M. Jung, J. Organomet. Chem. 1998, 568, 87-112; k) J. J. Eisch, X. Shi, F. A. 
Owuor, Organometallics 1998, 17, 5219-5221; l) K. M. Kane, P. J. Shapiro, A. 
Vij, R. Cubbon, Organometallics 1997, 16, 4567-4571; m) R. Teuber, R. 
Köppe, G. Lint, M. Tacke, J. Organomet. Chem. 1997, 545-546, 105-110; n) 
G. Erker, S. Wilker, Organometallics 1993, 12, 2140-2151; o) R. L. 
Haltermann, Chem. Rev. 1992, 92, 965-994. 
[9]  a) I. Erden, F.-P. Xu, A. Sadoun, W. Smith, G. Sheff, M. Ossun, J. Org. Chem. 
1995, 60, 813-820; b) S. J. Jacobs, S. A. Schulz, R. Javin, J. Novak, D. A. 
Dougherty, J. Am. Chem. Soc. 1993, 115, 1744-1753; c) K. J. Stone, R. D. 
Little, J. Org. Chem. 1984, 49, 1849-1853; d) G. Buchi, D. Berthet, R. 
Decorzant, A. Grieder, A. Hauser, J. Org. Chem. 1976, 41, 3208-3209; e) G. 
McCain, J. Org. Chem. 1958, 33, 632-633; f) J. H. Day, Chem. Rev. 1953, 53, 
167-189. 
[10] For a review refer to: a) M. Neuschwander in: The Chemistry of double 
bonded functional groups Part 2 (Ed.: S. Patai), John Wiley and Sons, 
Chichester, 1989, 1148-1172; b) K.-P. Zeller in:. Pentafulvenes. In Methoden 
der Organischen Chemie, Georg Thieme Verlag, Stuttgart, 1985; Vol. 5/2C, 
504-684; c) E. D. Bergmann, Chem. Rev. 1968, 68, 41-84. 
[11] K. Kutlescha, T. Irrgang, R. Kempe, Adv. Synth. Catal., accepted. 
[12] R. Knorr, A. Weiß, P. Löw, E. Räpple, Chem. Ber. 1980, 113, 2462-2489. 
[13] B. Blank, R. Kempe, J. Am. Chem. Soc. 2010, 132, 924-925. 
6. The Potassium Hydride Mediated Trimerization of Imines 
 76 
6.6 Supporting Information 
6.6.1 General  
Syntheses of the imine starting materials were performed under standard conditions. 
Fulvene syntheses were conducted in oven (95 °C) and vacuum dried glassware 
under an inert atmosphere of dry argon 5.0 via standard Schlenk or glove box 
techniques. NMR spectra were recorded on a Bruker ARX 250 (250 MHz) 
spectrometer or on a Varian Inova 300 or 400 (300 or 400 MHz). Chemical shifts are 
reported in ppm from TMS with the solvent resonance resulting from incomplete 
deuteration as the internal standard. Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration 
and coupling constant. Melting points were determined in sealed capillaries with a 
Stuart SMP3 melting point apparatus. Elemental analysis was performed with a Vario 
elementar EL III elemental analyzer. GC-MS analyses were performed on a Thermo 
Focus GC with DSQ-MS unit equipped with a HP-5-MS column (30m x 0.32mm x 
0.25!m). GC analyses were performed with an Agilent 6890 N Network GC-System 
equipped with a HP-5 column (30m x 0.32mm x 0.25!m). Non-halogenated solvents 
were distilled from sodium benzophenone ketyl and halogenated solvents from P2O5. 
Deuterated solvents were obtained from Cambridge Isotope Laboratories and were 
degassed, dried and distilled prior to use. All chemicals were purchased from 
commercial vendors and used without further purification.  
6.6.2 Synthesis of Imines  
N-Aryl imines were synthesized according to Taguchi et al.2 – a solution of 0.1 mol 
amine, 0.1 mol ketone and 40 g of molecular sieves (4 Å) in 20 mL of diethyl ether 
was stirred for 24 hours. The molecular sieves were filtered off and washed with 
ether.  The combined filtrates were evaporated to dryness and the residue was 
purified via vacuum distillation (liquid residue) or recrystallization. 
 
N-(1-phenylethylidene)aniline 1a: yielded as a pale yellow solid (14.66 g, 75 %). M.p. 
37 °C. Found: C, 86.0; H, 6.9; N, 7.3. Calc. for C14H13N (195.26): C, 86.1; H, 6.7; N, 
7.2%. "H (299.83 MHz, C6D6, 298 K, TMS) 7.97-7.94 (m, 2H, C6H5), 7.21-7.14 (m, 
5H, C6H5), 6.69-6.91 (t, 1H, C6H5, J = 7.2), 6.78-6.74 (m, 2H, C6H5) and 1.82 (s, 3H, 
 
2 K. Taguchi, F. H. Westheimer, J. Org. Chem. 1971, 1570-1572. 
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CH3); !C (75.39 MHz, C6D6, 298 K, TMS) 164.34 (C=N), 152.45, 139.69 (Cq, C6H5), 
130.40, 129.14, 128.31, 127.54, 123.20, 119.58 (Co,m,p, C6H5) and 16.63 (CH3). 
 
3-methyl-N-(1-phenylethylidene)aniline 1b: yielded as a pale yellow solid (11.00 g, 
53%). M.p. 34 °C. Found: C, 85.8; H, 7.4; N, 6.8. Calc. for C15H15N (209.29): C, 86.1; 
H, 7.2; N, 6.7%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.99-7.96 (m, 2H, aryl CH); 
7.18-7.12 (m, 4H, aryl CH); 6.80-6.78 (d, 1H, aryl CH, J = 7.5), 6.63-6.60 (d, 2H, aryl 
CH, J = 8.7), 2.14 (s, 3H, CH3) and 1.86 (s, 3H, CH3); !C (75.39 MHz, C6D6, 298 K, 
TMS) 164.10 (C=N), 152.54, 139.80, 139.67 (aryl Cq), 130.34, 129.04, 128.31, 
127.52, 123.98, 120.22, 116.64 (aryl CH), 21.37 (CH3) and 16.68 (CH3). 
 
4-methoxy-N-(1-phenylethylidene)aniline 1c: yielded as a pale yellow solid (19.40 g, 
86%). M.p. 86 °C. Found: C, 79.5; H, 6.7; N, 6.1. Calc. for C15H15NO (225.29): C, 
80.0; H, 6.7; N; 6.2%. !H (399.80 MHz, [d6]DMSO, 298 K, TMS) 8.00-7.97 (m, 2H, 
C6H5), 7.48-7.45 (m, 3H, C6H5), 6.95-6.93 (d, 2H, C6H4OCH3,  J = 8.4), 6.76-6.74 (d, 
2H, C6H4OCH3, J = 8.4), 3.75 (s, 3H, OCH3) and 2.21 (s, 3H, CH3); !C (100.53 MHz, 
[d6]DMSO, 298 K, TMS) 165.59 (C=N), 156.15, 144.94, 139.87, 131.02, 128.94, 
127.70, 121.40, 114.86 (aryl Cq, aryl CH), 55.82 (OCH3) and 17.64 (CH3). 
 
4-methoxy-N-(1-(p-tolyl)ethylidene)aniline 1d: yielded as a pale yellow solid (10.68 g; 
45%). M.p. 83 °C. Found: C, 80.2; H, 7.4; N, 5.9. Calc. for C16H17NO (239.31): C, 
80.3; H, 7.2; N, 5.85%. !H (299.83 MHz, CDCl3, 298 K, TMS) 7.91-7.89 (d, 2H, aryl 
CH, J = 8.1), 7.29-7.26 (d, 2H, aryl CH, J = 8.1), 6.95-6.92 (d, 2H, aryl CH, J = 9.0), 
6.80-6.77 (d, 2H, aryl CH, J = 9.0), 3.84 (s, 3H, OCH3), 2.44 (s, 3H, CH3) and 2.26 (s, 
3H, CH3); !C (75.39 MHz, CDCl3, 298 K, TMS): 165.79 (C=N), 156.11, 145.22, 
140.79, 137.33, 129.30, 127.36, 121.08, 114.47 (aryl Cq, aryl CH), 55.73 (OCH3), 
21.64 (p-CH3) and 17.49 (CH3). 
 
N-(1-(naphthalen-2-yl)ethylidene)aniline 1e: yielded as a pale yellow solid (10.07 g, 
60%). M.p. 140 °C. Found: C, 88.0; H, 6.1; N, 5.8. Calc. for C18H15N (245.32): C, 
88.1; H, 6.2; N, 5.7%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 8.51 (s, 1H, 2-
naphtyl), 8.23-8.20 (dd, 1H, 2-naphtyl, J = 1.8), 8.09-8.06 (m, 1H, 2-naphtyl), 8.00-
7.97 (m, 2H, 2-naphtyl), 7.61-7.58 (m, 2H, 2-naphtyl), 7.42-7.36 (t, 2H, Hm, C6H5), 
7.13-7.08 (t, 1H, Hp, C6H5), 6.86-6.83 (d, 2H, Ho, C6H5) and 2.33 (s, 3H, CH3); !C 
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(75.39 MHz, [d6]DMSO, 298 K, TMS): 164.83 (C=N), 151.36, 136.21, 133.90, 132.54 
(aryl Cq), 128.97, 127.90, 127.68, 127.52, 127.36, 126.51, 123.94, 123.12, 119.30 
(aryl CH) and 17.09 (CH3).  
 
2-methyl-N-(1-phenylethylidene)aniline 1f: yielded as a pale yellow solid (15.60 g, 
75%). M.p. 61 °C. Found: C, 85.7; H, 7.5; N, 6.7. Calc. for C15H15N (209.29): C, 86.1; 
H, 7.2; N, 6.7%. !H (399.83 MHz, [d6]DMSO, 298 K, TMS) 7.99-7.96 (m, 2H, C6H5), 
7.48-7.43 (m, 3H, C6H5), 7.20-7.18 (d, 1H, aryl CH, J = 7.6), 7.16-7.12 (t, 1H, aryl 
CH,  J = 7.6), 6.97-6.93 (t, 1H, aryl CH,  J  = 7.6), 6.60-6.59 (d, aryl CH, 1H, J = 7.6), 
2.09 (s, 3H, CH3) and 1.98 (s, 3H, CH3); !C (100.53 MHz, [d6]DMSO, 298 K, TMS) 
165.31 (C=N), 150.67, 139.50, 131.19, 130.83, 129.02, 127.74, 127.20, 127.05, 
123.72, 118.89 (aryl CH, aryl Cq), 18.10 (CH3) and 17.87 (CH3).  
 
N-(1-(p-tolyl)ethylidene)aniline 1g: yielded as a pale yellow solid (14.51 g, 70%). M.p. 
62 °C. Found: C, 85.7; H, 7.5; N, 6.8. Calc. for C15H15N (209.29): C, 86.1; H, 7.2; N, 
6.7%. !H (299.83 MHz, C6D6, 298 K, TMS) 7.94-7.91 (d, 2H, aryl CH, J = 8.1), 7.21-
7.14 (m, 4H, aryl CH), 7.02-6.99 (d, 2H, aryl CH, J = 8.1), 6.96-6.91 (t, 1H, aryl CH, J 
= 7.2), 6.78-6.75 (d, 2H, aryl CH, J = 7.2), 2.09 (s, 3H, CH3) and 1.86 (s, 3H, CH3); !C 
(75.39 MHz, C6D6, 298 K, TMS) 164.00 (C=N), 152.41, 140.30, 137.00 (aryl Cq), 
128.96, 128.92, 127.44, 122.92, 119.53 (aryl CH) and 21.00, 16.47 (CH3). 
 
3-chloro-2-methyl-N-(1-phenylethylidene)aniline 1h: yielded as pale yellow solid 
(17.80 g, 73%). M.p. 80 °C. Found: C, 73.8, H, 5.9; N, 5.7. Calc. for C15H17ClN 
(243.73): C, 73.9; H, 5.8; N, 5.75%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 8.03-
8.01 (d, 2H, C6H5, J = 7.6), 7.53-7.49 (m, 3H, C6H5), 7.19-7.16 (m, 2H, aryl CH), 
6.65-6.63 (d, 1H, aryl CH, J = 7.6), 2.15 (s, 3H, CH3) and 2.07 (s, 3H, CH3); !C 
(100.53 MHz, [d6]DMSO, 298 K, TMS) 166.18 (C=N), 151.86, 138.83, 134.35, 125.11 
(aryl Cq), 131.17, 128.77, 127.70, 127.55, 123.89, 117.74 (aryl CH), 17.79 (CH3) and 
14.72 (CH3).  
 
3,5-dimethyl-N-(1-phenylethylidene)aniline 1i: yielded as an orange liquid (14.40 g, 
65%). Found: C, 85.6, H, 7.5; N, 6.6. Calc. for C16H17N (223.31): C, 86.05; H, 7.7; N, 
6.3%. !H (299.83 MHz, [d6]DMSO, 298 K, TMS) 7.98-7.95 (m, 2H, C6H5), 7.48-7.46 
(m, 3H, C6H5), 6.69 (s, 1H, Hp, C6H3(CH3)2), 6.38 (s, 2H, Ho, C6H3(CH3)2), 2.26 (s, 
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6H, C6H3(CH3)2) and 2.17 (s, 3H, CH3); !C (75.39 MHz, [d6]DMSO, 298 K, TMS) 
164.40 (C=N), 151.37, 138.98, 137.95, 130.34, 128.23, 127.00, 124.49, 116.74 (aryl 
Cq, aryl CH), 20.92 (2 x CH3, C6H3(CH3)2) and 16.97 (CH3). 
6.6.3 Synthesis of Fulvenes 
General procedure: In a pressure tube 20.0 mmol of the imine 1 were dissolved in 
about 10.0 mL of THF. Then 0.57 g (14.0 mmol) of potassium hydride were added, 
immediately the color changed from orange to green and a second color change to 
dark red, accompanied by hydrogen evolution, took place. The dark brown solution 
was heated under slight reflux for three to four days. Then it was cooled to room 
temperature and water (about 5 mL) was added. The solution was extracted with 
diethyl ether (10 mL), the organic phase was dried over Na2SO4 and evaporated to 
dryness by rotary evaporation. The dark red product was purified via column 
chromatography (n-hexane/ ethyl acetate) or recrystallized. 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-phenyl-amine 2a: yielded 
as red crystalline product (1.18 g, 45%). M.p. 160-170 °C. Found: C, 90.3; H, 5.7; N, 
3.6. Calc. for C30H23N (397.51): C, 90.6; H, 5.8; N, 3.5%. !H (299.83 MHz, C6D6, 298 
K, TMS) 7.34-7.27 (m, 5H), 7.15-7.14 (d, 1H, J = 1.5), 7.13-7.12 (d, 1H, J = 2.1), 
6.92-6.67 (m, 9H), 6.43-6.39 (m, 4H), 6.29-6.24 (t, 1H, J = 7.5) and 5.90-5.87 (d, 2H, 
J = 7.5); !C (63,89 MHz, CDCl3, 298 K, TMS) 154.51, 141.83, 140.68, 139.21, 
138.75, 136.85, 136.46, 124.25 (Cq fulvene, aryl Cq), 133.08, 130.85, 130.80, 130.73, 
130.39, 130.21, 127.17, 122.86 (Co,m, aryl CH), 132.06, 129.02, 128.59, 127.87, 
125.27 and 121.95 (Cp, aryl CH, CH fulvene). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-m-tolyl-amine 2b: at -20 °C 
a red crystalline material (1.52 g, 57%) was obtained. M.p. 181-185 °C. Found: C, 
90.4; H, 6.05; N, 3.35. Calc. for C31H25N (411.54): C, 90.5; H, 6.1; N, 3.4%. !H 
(299.83 MHz, C6D6, 298 K, TMS) 7.62-7.60 (d, 4H, J = 8.1), 7.45-7.44 (d, 1H, J = 
1.5), 7.43-7.42 (d, 1H, J = 2.1), 7.20-6.94 (m, 11H), 6.73-6.72 (d, 1H, J = 1.8), 6.67-
6.62 (t, 1H, J = 7.8), 6.43-6.40 (d, 1H, J = 7.5), 6.08-6.06 (d, 1H, J = 7.8), 5.99 (s, 
1H) and 1.79 (s, 3H, CH3); !C (75.39 MHz, C6D6, 298 K, TMS) 151.32, 140.36, 
139.27, 138.50, 138.13, 137.21, 135.60, 135.01, 123.71 (aryl Cq, Cq fulvene), 131.34, 
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129.74, 128.77, 128.60, 126.27, 125.29, 125.36, 123.80, 121.72, 120.51, 117.99 
(aryl CH, CH fulvene) and 20.86 (CH3). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-p-methoxy-phenyl-amine 
2c: yielded as red crystalline product (0.77 g, 37%). M.p. 199 °C. Found: C, 87.4; H, 
5.9; N, 3.2. Calc. for C31H25NO (427.54): C, 87.1; H, 5.9; N, 3.3%. !H (399.83 MHz, 
CDCl3, 298 K, TMS) 7.63-7.58 (m, 6H), 7.52 (s, 1H), 7.48-7.17 (m, 9H), 7.19-7.15 (t, 
1H, J = 7.2), 6.92 (s, 1H), 6.62-6.60 (d, 2H, J = 8.4), 6.47-6.44 (d, 2H, J = 8.4), 6.42 
(s, 1H) and 3.71 (s, 3H, OCH3); !C (100.53 MHz, CDCl3, 298 K, TMS) 156.11, 
153.88, 138.90, 136.99, 136.44, 134.81, 134.09, 132.93 123.23 (aryl Cq, Cq fulvene), 
131.18, 128.89, 128.68, 128.39, 128.10, 125.14, 123.23, 114.11 (Co,m, aryl CH), 
129.92, 126.49, 126.45, 125.69, 120.01 (Cp, aryl CH, CH fulvene) and 55.33 (OCH3). 
 
[(2,4-di-p-tolyl-cyclopenta-2,4-dienylidene)-p-tolyl-methyl]-p-methoxy-phenyl-amine 
2d: In a pressure tube 3.59 g (15.00 mmol) of the imine 1d were dissolved in about 
10 mL of THF. Then 0.42 g (10.50 mmol) of potassium hydride were added, 
immediately the color changed from orange to green and a second color-change to 
dark red, accompanied by hydrogen evolution, took place. The dark brown solution 
was heated under slight reflux for three days, then cooled to room temperature and 
water (about 5 mL) was added. The solution was extracted with diethyl ether (10 mL) 
and the organic phase was dried with Na2SO4. At -20 °C a red crystalline material 2d 
(0.67 g, 29%) was obtained. M.p. 185 °C. Found: C, 86.5; H, 6.75; N, 2.85. Calc. for 
C34H31NO (469.62): C, 87.0; H, 6.65; N, 3.0%. !H (399.83 MHz, CDCl3, 298 K, TMS) 
7.47-7.41 (m, 7H), 7.16-7.07 (m, 6H), 6.81 (s, 1H), 6.59-6.57 (d, 2H, J = 8.4), 6.44-
6.21 (d, 2H, J = 8.4), 6.33 (s, 1H), 3.68 (s, 3H, OCH3), 2.39 (s, 3H, CH3) and 2.31 (s, 
6H, 2x CH3); !C (100.53 MHz, CDCl3, 298 K, TMS) 155.89, 153.71, 139.95, 136.21, 
135.90, 135.04, 134.26, 133.86, 133.20, 131.86, 120.82 (aryl Cq, Cq fulvene), 131.12, 
129.47, 129.00, 128.73, 128.46, 124.99, 123.27, 113.97 (aryl Co,m), 126.13, 119.16 
(CH fulvene), 55.25 (OCH3) 21.44 (CH3), 21.11(CH3) and 21.08 (CH3). 
  
[(2,4-di-naphtalen-2-yl-cyclopenta-2,4-dienylidene)-naphtalen-2-yl-methyl]-phenyl-
amine 2e: yielded as a red solid (0.50 g, 21%). M.p. 202 °C. Found: C, 92.0; H, 5.4; 
N, 2.4. Calc. for C42H29N (547.59): C, 92.1; H, 5.3; N, 2.6%. !H (399.83 MHz, C6D6, 
298 K, TMS) 8.20 (s, 3H), 7.83-7.7.78 (t, 2H, J = 9.2), 7.68-7.43 (m, 11H), 7.27-7.16 
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(m, 7H), 7.01 (m, 1H), 6.57-6.49 (m, 3H) and 6.16-6.15 (d, 2H, J = 7.2). !C (100.53 
MHz, CDCl3, 298 K, TMS) 152.61, 139.88, 137.46, 135.94, 134.87, 134.06, 134.03, 
133.91, 133.89, 132.72, 132.51, 132.22, 132.15, 123.11 (aryl Cq, Cq fulvene), 128.88, 
128.84, 128.30, 127.94, 127.88, 127.85, 127.78, 127.65, 127.52, 127.45, 126.71, 
126.62, 126.22, 125.91, 125.53, 124.96, 124.44, 123.45, 122.86 and 121.05 (aryl 
CH, CH fulvene). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-o-tolyl-amine 2f: yielded as 
a red solid (0.85 g, 31%). M.p. 165 °C. Found: C, 90.3; H, 6.0; N, 3.6. Calc. for 
C31H25N (411.54): C, 90.5; H, 6.1; N, 3.4%. !H (399.83 MHz, C6D6, 298 K, TMS) 
7.58-7.54 (m, 6H), 7.44-7.42 (m, 1H), 7.39-7.36 (m, 2H), 7.32-7.28 (m, 4H), 7.24-
7.22 (m, 2H), 7.18-7.12 (m, 1H), 6.99-6.97 (d, 1H, J = 6.4), 6.91-6.90 (d, 1H, J = 1.6), 
6.81-6.79 (m, 2H), 6.46-6.45 (m, 1H, J = 1.6), 6.37-6.35 (d, 1H, J = 6.4) and 1.75 (s, 
3H, CH3); !C (100.53 MHz, CDCl3, 298 K, TMS) 153.48, 139.02, 138.40, 137.41, 
137.08, 135.19, 134.79, 129.22, 122.52 (aryl Cq, Cq fulvene), 131.21, 130.62, 130.30, 
129.16, 129.08, 128.66, 128.42, 127.00, 126.90, 126.39, 126.12, 125.46, 123.74, 
122.16, 120.05 (aryl CH, CH fulvene) and 17.37 (CH3). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-p-tolyl-amine 2g: yielded 
as a red solid (1.52 g, 57%). M.p. 167 °C. Found: C, 90.2; H, 6.0; N, 3.3. Calc. for 
C31H25N (411.54): C, 90.5; H, 6.1; N, 3.4%; !H (399.83 MHz, CDCl3, 298 K, TMS) 
7.55-7.52 (m, 6H), 7.48-7.43 (m, 2H), 7.39-7.24 (m, 6H), 7.21-7.10 (m, 2H), 6.86 (s, 
1H), 6.81-6.79 (d, 2H, J = 7.6), 6.36 (s, 1H), 6.29-6.27 (d, 2H, J = 7.6) and 2.17 (s, 
3H, CH3); !C (100.53 MHz, CDCl3, 298 K, TMS) 153.14, 138.76, 137.17, 136.86, 
136.72, 134.84, 134.21, 133.14, 121.52 (aryl Cq, Cq fulvene), 131.06, 129.94, 129.38, 
128.84, 128.35, 128.12, 126.63, 126.51, 125.72, 125.12, 121.12, 119.94 (aryl CH, 
CH fulvene) and 20.66 (CH3). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-2-chloro-3-methyl-amine 
2h: yielded as a red solid (1.30 g, 44%). M.p. 205 °C. Found: C, 83.5; H, 5.0; N, 3.0. 
Calc. for C31H24ClN (445.98): C, 83.5; H, 5.4; N, 3.1%. !H (399.83 MHz, C6D6, 298 K, 
TMS) 7.63-7.61 (d, 2H, J = 8.0), 7.49-7.47 (d, 2H, J = 8.0), 7.41-7.38 (d, 2H, J = 7.2), 
7.22-7.20 (m, 2H), 7.10-7.6.91 (m, 9H), 6.77 (s, 1H), 6.72-6.70 (d, 1H, J = 7.6), 6.31-
6.28 (m, 2H) and 1.68 (s, 3H, CH3); !C (100.53 MHz, CDCl3, 298 K, TMS) 152.34, 
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139.73, 138.57, 137.86, 136.56, 134.79, 134.78, 134.64, 127.25, 123.19 (aryl Cq, Cq 
fulvene), 130.93, 130.14, 128.84, 128.42, 128.25, 127.31, 126.83, 126.23, 126.06, 
125.23, 124.30, 120.64, 119.72 (aryl CH, CH fulvene) and 13.65 (CH3). 
 
[(2,4-diphenyl-cyclopenta-2,4-dienylidene)-phenyl-methyl]-3,5-dimethyl-amine 2i:  
yielded as red solid (1.40 g, 49%). M.p. 214 °C. Found: C, 89.9; H, 6.4; N 3.5. Calc. 
for C32H27N (425.56): C, 90.3; H, 6.4; N, 3.3%. !H (399.83 MHz, C6D6, 298 K, TMS) 
7.68-7.63 (m, 4H), 7.49-7.48 (d, 2H, J = 6.8), 7.29 (s, 1H), 7.20-7.13 (m, 4H), 7.03-
7.02 (m, 6H), 6.77 (s, 1H), 6.29 (s, 1H), 5.93 (s, 2H) and 1.83 (s, 6H, 2x CH3); !C 
(100.53 MHz, CDCl3, 298 K, TMS) 153.09, 139.45, 138.79, 138.36, 136.87, 136.72, 
135.02, 134.21, 121.51 (aryl Cq, Cq fulvene), 130.99, 129.88, 128.87, 128.72, 128.36, 
128.06, 126.69, 126.47, 125.73, 125.12, 120.01, 118.84 (aryl CH, CH fulvene) and 
21.14 (2x CH3). 
6.6.4 Base optimization experiments 
Table 1: Variation of imine - potassium hydride ratio. 
No. Ratio imine : KH Conv.[a] [%] Main product[b] 
1 1.0 : 0.3 98.3 fulvene 
2 1.0 : 0.7 99.9 fulvene 
3 1.0 : 1.0 34.0 imine 
4 1.0 : 3.0 70.9 amine 
50 °C, 72h; [a] determined after workup via GC; [b] determined after workup via GC-MS 
Table 2: Base Screening. 
No. Base (0.7 eq.) Conv.[a] [%] 
1 KH 99.9 
2 KOH 22.0 
3 KOtBu 90.0 
4 LiH 51.0 
5 LiOtBu 0 
6 KOSiMe3 0 
7 NaNH2 70.0 
8 K2CO3 0 
50 °C, 72h; [a] determined after workup via GC  
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6.6.5 Kinetic experiments 
In a Schlenk tube 4.0 g (20.48 mmol) of 1a were dissolved in 25 mL THF, then 0.58 g 
KH (14.34 mmol) were added carefully. Thereby the color of the orange solution 
changed to green and later red with hydrogen being evolved. The Schlenk tube was 
stirred at 50 °C and periodically samples (0.6 mL) were taken. Water (1 mL), 
dodecane (93.15 !L) and 2 mL of diethyl ether were added to 500 !L of the sample. 
The organic phase was extracted and analyzed via GC-(MS). 
 
GC-MS analyses of kinetic-samples: 
Aniline:  MS (70 eV, EI); m/z (%): 93(M+, 100), 66(54). 
Imine:  MS (70 eV, EI); m/z (%): 195(M+, 40), 180(85), 118(20), 77(100). 
By-Product:  MS (70 eV, EI); m/z (%): 299(M+, 7), 284(11), 206(7), 194(23), 
180(34), 129(6), 105(43), 91(19), 77(100). 
 Hydrolysis of (1,3-diphenyl-butylidene)-phenyl-amine to aniline 
and 1,3-diphenyl-butan-1-one [224(M+, 10)] was observed after 
some days. 
Intermediate: MS (70 eV, EI); m/z (%): 297(M+, 6), 284(4), 194(6), 180(4), 
207(7), 184(7), 194(6), 180(4), 117(19), 91(100), 77(28), 65(10), 
51(39). 
Fulvene:  MS (70 eV, EI); m/z (%): 397(M+, 47), 319(7), 294(9), 215(14), 
180(29), 153(11), 77(10). 
 
Isolation of (1,3-diphenyl-butylidene)-phenyl-amine (“by-product”) 4a: In a 
pressure tube 4.0 g (20.48 mmol) of 1a were dissolved in 10 mL THF, then 0.58 g KH 
(14.34 mmol) were added carefully. Thereby the color of the orange solution changed 
to green and later red with hydrogen being evolved. The Schlenk tube was stirred at 
50 °C for 3 days. Then water (10 mL) was added. The organic phase was extracted, 
dried with Na2SO4 and reduced to dryness in vacuo. Pentane was added to the 
residue and red fulvene precipitated. The remaining solution was filtered, reduced to 
dryness in vacuo, and distilled in high vacuum yielding (1,3-diphenyl-butylidene)-
phenyl-amine as an orange viscous liquid (0.67 g, 22%). Found: C, 88.0; H, 7.2; N 
4.7. Calc. for C22H21N (299.41): C, 88.25; H, 7.1; N, 4.7%. "H (250.13 MHz, C6D6, 
298 K, TMS) 8.03-7.99 (m, 2H, C6H5), 7.32-7.10 (m, 9H, C6H5), 6.89-6.85 (m, 2H, 
C6H5), 6.67-6.64 (m, 2H), 3.13-3.02 (m, 1H, CH), 2.95-2.92 (m, 2H, CH2) and 1.10-
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1.07 (d, 3H, CH3, J = 7.0); !C (62.90 MHz, CDCl3, 298 K, TMS) 166.80 (C=N), 
151.25, 145.12, 138.69 (Cq, C6H5), 129.57, 128.35, 127.97, 127.88, 127.50, 126.46, 
125.92, 122.33, 118.87 (Co,m,p, C6H5), 38.14 (CH2), 37.68 (CH) and 20.61 (CH3). 
 
Synthesis of (1,3-diphenyl-but-3-enylidene)-phenyl-amine (“intermediate 
product”) 3a: To a solution of 4.00 g (18.00 mmol) of dypnone and 1.97 mL  (21.60 
mmol) aniline in 15 mL of benzene, 10.0 g molecular sieves (5 Å) and catalytic 
amounts of p-toluene sulfonic acid were added. The solution was refluxed for 5 days. 
The solution was filtered off the molecular sieves, and washed with diethyl ether. The 
organic phase was evaporated to dryness via rotary evaporation. Then the aniline 
and dypnone were removed by vacuum distillation. The remaining orange-brown 
solid was recrystallized from ether/hexane yielding 1.20 g (22%) of (1,3-diphenyl-but-
3-enylidene)-phenyl-amine as orange needles. Found: C, 88.45; H, 6.4; N 4.3. Calc. 
for C22H19N (297.39): C, 88.85; H, 6.4; N, 4.7%. !H (250.13 MHz, C6D6, 298 K, TMS) 
8.26-8.22 (m, 2H, C6H5), 7.33-7.12 (m, 11H, C6H5), 7.03-6.97 (m, 2H), 6.43 (s, 1H, 
CH) and 1.76 (s, 3H, CH3); !C (62.90 MHz, CDCl3, 298 K, TMS) 165.32 (C=N), 
151.55, 141.04, 141.01, 138.88 (Cq, C6H5, C-CH3), 130.08, 128.09, 127.97, 127.92, 
127.86, 127.40, 125.41, 123.35, 122.65, 120.40 (Co,m,p, C6H5, CH) and 18.26 (CH3). 
6.6.6 X-Ray Crystallographic Data  
Molecular Structure of 2a 
X-ray crystal structure analysis of 2a, STOE-IDPS II equipped with an Oxford 
Cryostream low temperature unit, graphite monochromatized MoK"-radiation, 
#=0.71069 Å, structure solution and refinements were accomplished with SHELXL-97 
(G. M. Sheldrick, SHELXL-97, Program for Crystal Structure Analysis Release 97-2, 
Institut für Anorganische Chemie der Universität, Göttingen, Germany, 1998), WinGX 
(L. J. Farrugia, J. Appl. Crystallogr. 1999, 32, 837-838) und SIR97 (A. Altomare, M. 
C. Burla, M. Camalli, G. L. Cascarano, C. Giacovazzo, A. Guagliardi, A. G. G. 
Moliterni, G. Polidori, R. Spagna, J. Appl. Cryst. 1999, 32, 115-119), crystal size 0.56 
x 0.41 x 0.35 mm, red prisms, symmetry space group P21/n, monoclinic, a = 
11.4870(8), b = 10.7950(8), c = 17.4210(13) Å, ß= 101.575(5)°, V = 2116.3(2) Å3 , Z 
= 4, !ber. = 1.248 g/cm3, 3993 measured reflections, 2986 independent reflections, R 
= 0.0330 [I > 2$(I)], wR2 (all data) = 0.0746, 373 parameters. CCDC-782978 contains 
the supplementary crystallographic data for this publication. These data can be 
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obtained free of charge at www.ccdc.cam.ac.uk/data_request/cif (or from the 
Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; 
Fax: + 44-1223-336-033; E-mail: deposit@ccdc.cam.ac.uk). 
Figure 7: Molecular structure of 2a; selected bond lengths [Å] and angles [°] for 2a: 
C1-N1, 1.3662(15); C1-C2, 1.3751 (16); C2-C3, 1.4483(17); C3-C4, 1.3563(17); C4-
C5, 1.4496(17); C5-C6, 1.3587(17); C6-C2, 1.4676(17); N1-C1-C2, 122.19(11); N1-
C1-C25, 116.17(10); C1-N1-C19, 128.98(11). 
Molecular Structure of 2c 
X-ray crystal structure analysis of 2c, crystal size 0.39 x 0.26 x 0.13 mm, red prisms, 
symmetry space group P21/n, monoclinic, a = 10.0630(8), b = 15.9800(13), c = 
13.9950(12) Å, ß=93.129(7)°, V = 2247.1(3) Å3, Z = 4, !ber. = 1.264 g/cm3, 4256 
measured reflections, 2494 independent reflections, R = 0.0534 [I > 2!(I)], wR2 (all 
data) = 0.0880, 303 parameters. CCDC-782980 contains the supplementary 
crystallographic data for this publication.  
Figure 8: Molecular structure of 2c; selected bond lengths [Å] and angles [°] for 2c: 
C1-N1, 1.362(3); C1-C2 1.378(3); C2-C3, 1.444(3); C3-C4, 1.360(3); C4-C5, 1.451(3); 
C5-C6, 1.362(3); C6-C2, 1.461(3); N1-C1-C2, 121.5(2); N1-C1-C26, 116.89(19); C1-
N1-C19, 127.1(2). 
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Molecular Structure of 5a 
X-ray crystal structure analysis of 5a, crystal size 0.48 x 0.08 x 0.08 mm, yellow 
needles, symmetry space group P-1, triclinic, a = 9.2950(11), b = 11.2290(15), c = 
13.2300(16) Å, ß= 90.466(10)°, V = 1349.2(3) Å3, Z = 2, !ber. = 1.250 g/cm3, 5098 
measured reflections, 1784 independent reflections, R = 0.0561 [I > 2!(I)], wR2 (all 
data) = 0.0989, 334 parameters. CCDC-782979 contains the supplementary 
crystallographic data for this publication.  
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